Oncology Books

Book SynopsisOur fear of cancer causes great harm to individual health and to society. The fear of cancer is understandable. But that fear is in some ways outdated, as it fails to account for the medical progress made against this family of diseases. In Curing Cancerphobia, David Ropeik reveals the fascinating historical and psychological roots of our fear of cancer and documents the dramatic health and financial harms caused when that fear exceeds the risk. Fear of cancer drives millions for whom screening is not recommended to screen for the disease anyway, producing tens of thousands of emotionally damaging false positives and costing the US health care system an estimated $9.2 billion a year. At the same time, fear of cancer also causes many people for whom screening is recommended to avoid it altogether. Modern screening technologies often identify cancers that do not spread or that grow so slowly they almost certainly will never cause harm in a person's lifetime. Yet many of these peoplTrade ReviewAs an oncologist and caregiver of a spouse with cancer, I felt very close to the issues raised and the coverage of the subject matter. I hope that this book will reach a broad audience to stimulate an open discussion on this topic.—John L. Marshall, MD, Georgetown University HospitalTable of ContentsIntroductionPart One. The Origins of Our Fear of CancerChapter 1. The Historical RootsChapter 2. The Psychological RootsPart Two. The Costs to IndividualsChapter 3. Overscreening, Overdiagnosis, Overtreatment: An OverviewChapter 4. Breast Cancer: When Worry Causes Us to Do Too MuchChapter 5. Prostate Cancer: When Worry Causes Us to Do Too MuchChapter 6. Thyroid Cancer: When Worry Causes Us to Do Too MuchChapter 7. Lung Cancer: When Worry Causes Us to Do Too MuchChapter 8. Colorectal Cancer: When Worry Causes Us to Do Too MuchChapter 9. Underscreening: When Fear Scares Us Out of Doing EnoughChapter 10. Delayed Diagnosis: When Fear Scares Us Out of Doing EnoughPart Three. The Costs to SocietyChapter 11. The Stunning Economic Cost of Our Sometimes Excessive Fear of CancerChapter 12. Environmentalism's Contribution to Our Fear of CancerChapter 13. Other Societal Impacts of Our Fear of CancerPart Four. Reducing the CostsChapter 14. Combating CancerphobiaChapter 15. Combating Cancerphobia in YourselfAcknowledgmentsNotesIndex

Read more less

Book SynopsisDomini Kemp and Patricia Daly, who have both come through cancer, have discovered a life-changing way of eating.In The Ketogenic Kitchen they share with you exciting nutritional developments, which reveal that a diet low in carbohydrates and high in fat, in conjunction with the treatment recommended by medical professionals, offers new hope in the support of and protection against many chronic illnesses.Whether you are facing treatment, going through recovery or simply want to choose food that can keep you in long-term optimal health, The Ketogenic Kitchen offers advice and delicious recipes that will aid weight loss and leave you with higher energy levels and glowing good health.

Read more less

Book SynopsisAcupuncture can play a vital role in helping the growing number of cancer survivors adjust to life after receiving cancer treatments, including surgery, chemotherapy, and radiotherapy. This includes managing the physical and emotional after-effects of diagnosis and treatment, making healthy lifestyle choices, coping with fear of recurrence, learning how to manage a chronic condition, and establishing the "new normal" that is the legacy of a cancer diagnosis and its treatments.As a guide for practitioners, it aims to help acupuncturists to:· Understand the challenges faced by cancer survivors who have completed treatment (surgery, chemotherapy, radiotherapy)· Understand the biomedical context of the consequences of cancer treatments· Relate their patient's cancer experience to the principles of east Asian medicine· Treat some specific consequences of cancer treatment· Work safely with cancer survivors· Support cancer survivors on an emotional level· Help patients come to terms with a chronic condition and adjust to the "new normal" · Manage expectations of both patient and practitioner· Access the research that has been conducted in this field.Trade ReviewThis beautifully written book has the advantage of coming from the perspective of a highly experienced practitioner-academic. Dr de Valois combines her knowledge of acupuncture in private practice, and experience of working in an integrated healthcare team in the NHS; detailing biomedical and acupuncture approaches to managing the consequences of cancer treatments. -- Dr Christine A Barry BA, BSc, PhD Medical Anthropology Senior Research Fellow, Brunel University (retired)This makes me feel I have the skills to be able to offer something good to cancer survivors. I find the honesty and clarity of Beverley's writing in sharing her own approach and experiences very empowering -- Maggie Bavington Lic Ac, MSc Chinese Herbal Medicine Acupuncturist and HerbalistBeverley de Valois is the acupuncture authority on cancer survivorship in the UK and West. This ground-breaking book reflects her in-depth knowledge and extensive expertise. -- Angela Hicks BSc LicAc FBAcC MRCHM Co-founder and President, College of Integrated Chinese Medicine, Reading, Berkshire UKThis book is an exciting and important new resource in the evidence-informed practice of acupuncture for supporting cancer survivors. I wish I had had it during my years in a hospital oncology service; this is a large population of patients with deep needs for continuing care that may not be effectively addressed by a system that is set up for crisis management. Dr. de Valois' decades of experience in listening to and caring for these patients are plainly evident, and shine through her careful presentations of what is needed and how we can be of help. -- Dr Claudia Citkovitz PhD MS LAC Adjunct Faculty, Massachusetts College of Pharmacy and Health Sciences. Author, Acupressure and Acupuncture During Birth.This book has been anticipated by practitioners and acupuncture students alike. Extending beyond the TCM patterns for cancer, this manual will serve as a wonderful resource for acupuncturists working with cancer patients covering all the softer issues that come with this area of work as well as diagnosis and treatment options in acupuncture. It is filled with information gathered over many years by the author, who has a great wealth of experience both as a practitioner and as a researcher.Beverley has brought together years her unique experience working withcancer survivorship as a Chinese medicine practitioner in this book. It willprovide a new generation of practitioners with most valuable support andguidance that is both practical and useful in a clinical setting. * Kim Chan BA (Hons), MA, LicAc, MBAcC Programme Leader for Acupuncture Skills, Chinese Medicine Lecturer and Clinical Supervisor, College of Integrated Chinese Medicine, Reading, Berkshire UK *This book will be invaluable for practitioners of course but also for their clients. The book will facilitate the deepening of the therapeutic relationship * Isobel Cosgrove BA[SS], MA[Oxon]MLitt, FBAcC Acupuncturist and Founder of UK Supervision Network, London, UK *a valuable resource for practitioners; very informative, clear, written with an intelligent heart * Margré de Vries, LicAc, BSc (Hons) Acupuncture, Dip Shiatsu DO Acupuncture and Shiatsu practitioner, London UK *This is a wonderfully written book which is easy to digest, balancing Beverley's research and clinical experience. * Amy Din MSc BSc (Hons) Dip MBAcC Traditional Acupuncturist. Senior Research Assistant, Trial Coordinator, PhD candidate, University of Southampton, UK *Clear, knowledgeable, practical and diverse information .... this is a must for an acupuncturist's book shelf/reference . * Rachel Peckham MSc LicAc FBAcC Acupuncturist. Trustee and trainer, NADA GB, London UK *A key strength of this unique text is the content on lymphoedema and the importance of adapting acupuncture techniques for risk reduction and safe practice. I love the detailed case studies providing numerous practical tips. * Margaret Sneddon, British Lymphology Society Chair *

Read more less

Book SynopsisCompletely reorganized to be more clinically focused on diagnosis and treatment, Principles and Practice of Gynecologic Oncology, Eighth Edition, provides the up-to-date information practitioners, researchers, and students need in an easily accessible manner. Drs. Dennis S. Chi, Dineo Khabele, Don S. Dizon, and Catheryn Yashar oversee an expert team of international, multidisciplinary authors who offer practical coverage of the entire field, including new management and treatment strategies for gynecologic cancers. Each disease site now has a dedicated section with individual chapters on epidemiology, pathogenesis, prevention, diagnostic imaging, radiation, chemotherapy, targeted therapy, and more—all designed for  quick clinical reference and efficient study.  Features a multidisciplinary approach to treatment and care including expert views from radiation oncology, pathology, internal medicine, gastroenterology and nutrition, neurology

Read more less

Book SynopsisFocusing on individual patient needs, Cancer Chemotherapy, Immunotherapy and Biotherapy:  Principles and Practice, Seventh Edition, provides thorough, comprehensive information from Drs. Bruce A. Chabner, Dan L. Longo, and an authoritative team of clinicians and scientists working at renowned cancer centers across the globe. It covers fundamental information about mechanism of action, pharmacokinetics, clinical toxicity, and drug interactions, all essential to the safe and effective use of the drug. Features full-color illustrations, numerous tables for quick reference and new content that brings you fully up to date with the state of the art in all current cancer therapies Contains the latest information on immunotherapy and molecular targeted therapy as well as all drugs and biological agents, their mechanisms of action, interactions with other agents, toxicities, side effects, and mechanisms of resistance Reflects

Read more less

Book SynopsisConcise, portable, and packed with essential information, Manual of Clinical Oncology is an indispensable resource for understanding basic science, clinical findings, and available technology as they relate to the diagnosis and management patients with cancer. The practical format provides high-yield content useful for participating in rounds ad making diagnostic and therapeutic decisions at the bedside. Edited by Dr. Bartosz Chmielowski and Dr. Mary Territo, both from UCLA School of Medicine, this eighth edition carries on the tradition of excellence set forth by longtime editor Dr. Dennis Casciato.Key Features: Incorporates recent major achievements in immunotherapies, biologics, and targeted therapies. Features new chapters on the biology of cancer, immunotherapy, and cancer survivorship. Contains numerous diagnostic and treatment algorithms, as well as content on complications, for assistance with clinical decision making. Includes hTrade Review“Now in its eighth edition, this remarkable, concise, and portable manual is packed with essential information that seamlessly integrates basic science and clinical sciences with technological advances as they relate to the diagnosis, prognosis, treatment, and management of a variety of cancer types.The manual is well organized into four major sections: general aspects, solid tumors, hematological malignancies, and complications. Each section contains several chapters written by experts actively engaged in clinical research. While Sections 2 and 3 cover the most common cancers and contain the expected information, it is Section 4 that is quite remarkable, providing useful information on complications ranging from metabolic complications to those from stem cell transplantation, which is uncommon in standard works in this area.A unique selling point of this book is the outline format with bold headings and subheadings that makes it easy to access pertinent information and makes up for the (almost) total lack of figures and illustrations.Amazingly, although this manual is almost 900 pages, it is quite handy and portable. Overall, it is an indispensable resource that should be a part of every oncology library.”Weighted Numerical Score: 94 - 4 Stars!Doodys Publishers' Club, March 2018

Read more less

Book SynopsisSelected as a Doody's Core Title for 2022 and 2023! Offering up-to-date, authoritative information in a quick-reference format, The Bethesda Handbook of Clinical Oncology, Sixth Edition, is a comprehensive yet concise review of the management of different cancer types. Drs. Jame Abraham, James L. Gulley, and a team of expert contributors emphasize practical information that can be applied in everyday patient care situations, and thoroughly revised content keeps you current with advances in this fast-changing field. Provides practical guidance on evaluation, diagnosis, and treatment of patients with cancer from experts and scholars at the National Cancer Institute, National Institutes of Health, Cleveland Clinic, and other renowned institutions. Covers a range of solid-tumor, blood, and other cancers, as well as immunotherapeutic drugs, infection management, nutrition, and palliative care. Contains new and revised content on immunotherapy, precision medicine, genetics, individual cancer therapies, and more. Helps you find what you need quickly with concise, clear content and numerous tables, algorithms, and figures throughout. Enrich Your eBook Reading Experience Read directly on your preferred device(s),such as computer, tablet, or smartphone. Easily convert to audiobook,powering your content with natural language text-to-speech.

Read more less

Book SynopsisThis is the ideal companion for postgraduate pain medicine exams and a comprehensive guide to acute, chronic, and cancer pain management for practising doctors, pain nurses, and allied health professionals.Table of ContentsSection 1 - Overview of Pain 1: Sabina Bachtold, Enrique Collantes, Praveen Ganty, Yehia Kamel, Gustav Jirikowksi, Deepak Ravindran, Jan Rudiger, Alifia Tameem, and John Tanner: Types of Pain and Pain Assessment Section 2 - Pain Physiology 2: Enrique Collantes, Gustav Jirikowski, Paolo Pais, Deepak Ravindran, Jan Rudiger, and Maria Stasiowska: Pain Pathways 3: Ramy Mottaleb, Nofil Mulla, and Maria Stasiowska: Neurotransmitters and receptors 4: Bethany Fitzmaurice, Senthil Jayaseelan, Gustav Jirikowski, Sandeep Kapur, and Manish Mittal: Neurobiology of Pain Section 3 - Pharmacology 5: Nishi Patel and Kathleen Shelley: Basic Principles of Pharmacology 6: Enrique Collantes, Kavita Poply, and Jan Rudiger: Local anaesthetics 7: Enrique Collantes, Praveen Ganty, James Jack, Jonathan Norman, and Jan Rudiger: Opioids 8: Peter Keogh: Non-steroidal anti-inflammatory drugs and paracetamol 9: Mohammed Sajad and Alifia Tameem: Anticonvulsants 10: Hadi Bedran, Enrique Collantes, and Peter Keogh: Antidepressants 11: Hadi Bedran: Neurolytic agents 12: Sadiq Bhayani, Bethany Fitzmaurice, and Alifia Tameem: Corticosteroids 13: Hadi Bedran, Udaya Chakka, Bethany Fitzmaurice, Praveen Ganty, James Jack, Peter Keogh, Arumugam Pitchiah, Kavita Poply, Manamohan Rangaiah, Jan Rudiger, Maria Stasiowska, and Alifia Tameem: Miscellaneous 14: Sabina Bachtold, Rahul Guru, Katharine Howells, James Jack, Sandeep Kapur, Jan Rudiger: Clinical pharmacology Section 4 - Pain interventions 15: Adnan Al-Kaisy, Simon Braude, Enrique Collantes, Sumit Gulati, Ashok Puttapa, Jan Rudiger, Haggai Sharon, and Alifia Tameem: Overview of interventions 16: Ann-Katrin Fritz and Jan Rudiger: Head and Neck 17: Laura Beard, Mohamed Dorgham, Rahul Guru, Doug Stangoe, and Alifia Tameem: Thorax and abdomen 18: Sadiq Bhayani, Yehia Kamel, Bhavesh Raithatha, Jan Rudiger, and Tom Smith: Lumbar and pelvis 19: Ann-Katrin Fritz, Rahul Guru, Gustav Jirikowski, Bhavesh Raithatha, Subramanian Ramani, and Jan Rudiger: Autonomic nervous system 20: Sangeeta Das, Gustav Jirikowski, Yehia Kamel, Deepak Malik, Manish Mittal, Yin Yee Ng, Stefano Palmisani, David Pang, Jan Rudiger, Athmaja Thottungal: Spinal cord and neuromodulation 21: Erlick AC Perreira: Surgical techniques 22: Hadi Bedran, Sadiq Bhayani, Bill Clark, Llya Kantsedikas, Andrzej Krol, Attam Singh, and John Tanner: Miscellaneous interventions Section 5 - Clinical 23: Owen Bodycombe, Enrique Collantes, Mohammed Dorgham, Bethany Fitzmaurice, Rahul Guru, Yehia Kamel, Sandeep Kapur, Nofill Mulla, Paolo Pais, Arumugam Pitchiah, Shankar Ramaswamy, Jan Rudiger, Tom Smith , Athmaja Thottungal, and Ivan Wong: Musculoskeletal pain conditions 24: Sabina Bachtold, Owen Bodycombe, Sumit Gulati, Rajesh Gupta, Rahul Guru, Nofill Mulla, Ashok Puttapa, Erlick AC Perreira, , Jan Rudiger, Tom Smith, Kantaruby Tambirajoo, Alifia Tameem, Athmaja Thottungal: Neuropathic pain conditions 25: Sian Griffith: Rheumatological conditions 26: Enrique Collantes, Paolo Pais, Jan Rudiger, and Athmaja Thottungal: Visceral pain conditions 27: Enrique Collantes, Nofill Mulla, Kavita Poply: Widespread chronic pain 28: Enrique Collantes, Anthony Gubbay, Sumit Gulati, Sarah Harper, Tommy Lwin, Nofill Mulla, Paolo Pais, David Pang, Shankar Ramaswamy, Jan Rudiger, Kantaruby Tambirajoo, Victoria Winter, and Ivan Wong: Other pain conditions Section 6 - Cancer and Pain 29: Kasia Chmiel, Mahesh Choudhari, Alix Dumitrescu, Yehia Kamel, Ashok Puttapa, and Alifia Tameem: Cancer and Pain Section 7 - Psychology of pain medicine 30: Sabina Bachtold, Caroline Burrow, Rahul Guru, and Karen LeMarchand: Psychology and Pain Section 8 - Physiotherapy and Occupational Therapy 31: Rebecca Pardoe and Fiona Thomas: Physiotherapy and Occupational Therapy Section 9 - Epidemiology & Statistics 32: Sabina Bachtold, D. Pang, and Alifia Tameem: Epidemiology & Statistics

Read more less

Book SynopsisNow fully revised and in its fourth edition, the Oxford Handbook of Oncology has been the essential go-to guide for students and practitioners in oncology for over a decade. The scientific basis and diagnosis of cancers is covered, as well as drugs, biomarkers, and the presentation and psychosocial aspects of oncology. Concise, practical, and comprehensive, there is no better companion for both common conditions and challenging emergencies.The field of oncology has surged forward since the last edition was published and the Oxford Handbook of Oncology has been fully revised and updated to reflect these recent advances so you can be sure that the vital information you need is in your hands. This handbook incorporates changes such as the understanding of the science of cancer, novel therapies in breast, lung, renal, and melanoma, molecular sub-classification of common solid cancers, personalized therapy approaches, new agents in hard to treat cancers, the benefits of new technologies in Trade ReviewWritten by experts in the field to ensure that it is grounded in real life clinical practice, this Handbook provides a concise guide to all aspects of oncology for all students, nurses, and junior faculty responsible for the care of cancer patients, while also providing further reading and highlighting areas of controversy for those who need a more detailed understanding. * Anticancer Research *Table of Contents1. Multidisciplinary approach to cancer ; 2. Aetiology and epidemiology ; 3. Genetics of cancer ; 4. Surgical oncology ; 5. Principles of radiation oncology ; 6. Principles of chemotherapy ; 7. Principles of symptom control in palliative care ; 8. Late effects of radiotherapy and chemotherapy ; 9. Hormone therapy ; 10. Biological and targeted therapies ; 11. Clinical trials ; 12. Cancer prevention ; 13. Population screening for cancer ; 14. Thoracic cancer ; 15. Breast cancer ; 16. Colorectal cancer ; 17. Anal cancer ; 18. Upper gastrointestinal cancer ; 19. Endocrine cancers ; 20. Genitourinary cancers ; 21. Gynaecological cancer ; 22. Head and neck cancer ; 23. Tumours of the central nervous system ; 24. Skin cancer ; 25. Haematological malignancies ; 26. Bone and soft tissue malignancies ; 27. Cancer of unknown primary site ; 28. Paraneoplastic syndromes ; 29. AIDS-related malignancies ; 30. Childhood cancers presenting in adulthood ; 31. Overview of Acute Oncology ; 32. Spinal cord compression and bone marrow suppression ; 33. Superior vena cava obstruction and raised intracranial pressure ; 34. Stridor ; 35. Thromboembolic and cardiac emergencies ; 36. Obstruction ; 37. Biochemical crises ; 38. Complications of long-term central venous lines and chemotherapy extravasation ; 39. Novel therapeutic strategies ; 40. Gene therapy and immunotherapy for cancer ; 41. Biomarkers and Cancer ; Appendices

Read more less

Book SynopsisFully updated to include a new introduction by Lynda Thomas, CEO of Macmillan Cancer Support.''I can''t bear not to be with these three most important people in my life. I can''t bear not to be there alongside Mark as my children grow up. My bright, funny, affectionate boys who are never embarrassed to say, love you mummy, and say it ten times day.'' Renowned as a much-loved and highly respected BBC journalist, Victoria Derbyshire has spent 20 years finding the human story behind the headlines. In 2015 she found herself at the heart of the news, with a devastating breast cancer diagnosis. With honesty and openness, she decided to live out her treatment and recovery in the spotlight in a series of video diaries that encouraged thousands to seek diagnosis and help. Victoria has kept a diary since she was nine years old and in DEAR CANCER, LOVE VICTORIA she shares her day to day experiences of life following her diagnosis and coming to Trade ReviewVictoria is exactly the type of friend everyone would want by their side after being diagnosed with cancer. Although her story is at times heartbreaking, it is also frank, funny and succeeds in demystifying an illness often discussed in hushed tones. -- Elizabeth Archer * DAILY EXPRESS *'This powerful account of Victoria Derbyshire's struggle to deal with her breast cancer diagnosis is told with honesty and courage that gives strength to those touched by cancer.' DAILY TELEGRAPH[Victoria Derbyshire] shares her day to day experiences of life folloiwng her diagnosis and coming to terms with a future that wasn't planned. From the moment she woke up to find her right breast had collapsed, to telling her partner and children, through to mastectomy and chemotherapy, we are there with her. * GOOD HOUSEKEEPING *'Wonderful, courageous, spirited and just plain honest...a gift to all those folk who are suddenly blasted into the scary, bleak world of cancer.' Dame Julie Walters'Truly brilliant' Claudia Winkleman'A really good, searingly honest book...a must read' Lorraine Kelly'A powerful diary... highlighting the huge value of support.' Susanna ReidThe broadcaster - and mother of two - has written an affectingly honest diary of her treatment for breast cancer. * READERS DIGEST *

Read more less

Book SynopsisIf you or someone you love has been diagnosed with cancer, you want to do everything possible to beat the disease. But with so much conflicting advice and so many options available, how do you decide on the best treatment plan for you?In this major new book, Professor Jane Plant and Professor Mustafa Djamgoz present a clear and scientifically sound 10-step programme to help you beat cancer. At a time when you may be feeling helpless and confused, this book provides the essential guidance you need to take control of your life and regain your health with targeted advice for specific cancers.Included in the 10-step plan: Inform yourself: understand what cancer is, what causes it and how to avoid carcinogens Choosing the right treatment: evidence-based advice on conventional and complementary therapies, including chemotherapy, radiotherapy, surgery and medication Change your lifestyle: guidance on diet, exercise, reducing stress, relationships and other lifestyle factors that have a proven link with cancerBeat Cancer will help you prevent cancer, tackle your diagnosis and stay in remission.Trade Reviewthis sensitive and informative self-help guide goes into every aspect of cancer in great detail, from debunking myths of the disease to what to expect before a chemo session * Daily Mail *

Read more less

Book SynopsisIn 1961 John F. Kennedy pledged to put a man on the moon by the end of the decade. Nine years later, Neil Armstrong and Buzz Aldrin walked on the moon. Ten years later, Richard Nixon echoed this pledge by declaring a ''war'' on cancer. More than 50 years later, however, cancer remains one of the largest causes of death worldwide, with around 1 in 3 developing the disease. Curing cancer is not ''rocket science'', but the question is, why has cancer proved to be harder to tackle than the moon landings turned out to be? Cancer research is a major economic activity. There are constant improvements in treatment techniques that result in better cure rates and increased quality and quantity of life for those with the disease, yet stories of breakthroughs in a cure for cancer are often in the media. In this Very Short Introduction Nick James examines the trends in diagnosis and treatment of the disease, as well as its economic consequences. Asking what cancer is and what causes it, he considers issues surrounding expensive drug development, what can be done to reduce the risk of developing cancer, and the use of complementary and alternative therapies. This edition includes a new chapter on the growing role of evolution theory in understanding cancer. ABOUT THE SERIES: The Very Short Introductions series from Oxford University Press contains hundreds of titles in almost every subject area. These pocket-sized books are the perfect way to get ahead in a new subject quickly. Our expert authors combine facts, analysis, perspective, new ideas, and enthusiasm to make interesting and challenging topics highly readable.

Read more less

Book Synopsis

Read more less

Book SynopsisThis sixth edition of the Oxford Textbook of Palliative Medicine takes us now into the third decade for this definitive award-winning textbook. It has been rigorously updated to offer a truly global perspective, highlighting the best current evidence-based practices, and collective wisdom from more than 200 experts around the world. This leading textbook covers all the new and emerging topics, updated and restructured to reflect major developments in the increasingly widespread acceptance of palliative medicine as a fundamental public health need. The sixth edition includes new sections devoted to family and caregiver issues, cardio-respiratory symptoms and disorders, and genitourinary symptoms and disorders. In addition, the multi-disciplinary nature of palliative care is emphasized throughout the textbook, covering areas from ethical and communication issues, the treatment of symptoms, and the management of pain.The Oxford Textbook of Palliative Medicine is a truly comprehensive textTrade ReviewReview from previous edition Featured as an essential purchase on Doody's Core Titles List for 2018This book is an excellent resource, full with information from leaders in the field of palliative medicine [...] An essential textbook for all professionals working within the palliative care arena. * Helen Reeves, Clinical Nurse Manager, St Giles Walsall Hospice, Nursing Times *This is an expertly informed text that remains authoritative and detailed. Seeing all these chapter titles in print also illustrates how broad palliative care is, providing a useful reminder of how many different areas and topics are part of its practice [...] Those new to the book will find what the editors hope to have created: an authoritative reference text with a global perspective on the field. * Guy Schofield, Clinical Research Fellow, Imperial College, London; in the European Journal of Palliative Care, Vol 23, No. 1 (2016) *Updated, well organised, and the coverage is good [...] I think it remains the best book on palliative medicine on the market. * Roger Woodruff; Hospicecare.com, January 2016 *Table of ContentsSection 1: The worldwide status of palliative care 1.1: Carlos Centeno, Sheila Payne, and Eduardo Garralda: International progress in the development of palliative care 1.2: Lukas Radbruch and Liliana De Lima: Essential medicines for palliative care 1.3: Frank Brennan and Liz Gwyther: Human rights issues 1.4: Stephen R. Connor: Policy in palliative care Section 2: The challenge of palliative medicine 2.1: Russell K. Portenoy: Building definitional consensus in palliative care 2.2: Nathan I. Cherny and Russell K. Portenoy: Core concepts in palliative care 2.3: Davinia Seah, David Marco, Jennifer Philip, and Megan B. Sands: The epidemiology of death and symptoms: planning for population-based palliative care 2.4: Barry Laird, Erna Haraldsdottir, and Charlie Hall: Barriers to the delivery of palliative care 2.5: Jonathan Koffman and Natalia Calanzani: Ethnic and cultural aspects of palliative and end of life care 2.6: Peter S. Hall, Katharina Diernberger, and Liz Grant: Health economics for palliative care Section 3: Service delivery issues in palliative care 3.1: Breffni Hannon, Stein Kaasa, and Camilla Zimmermann: Specialist palliative care along the trajectory of illness: issues in the early integration of palliative care 3.2: Irene J. Higginson: Palliative care delivery models 3.3: Sharon Einav, Nathan I. Cherny, and J. Randall Curtis: Palliative medicine in the intensive care unit 3.4: Naomi George and Corita Grudzen: Palliative care in the emergency department 3.5: Jane Phillips and Annmarie Hosie: Palliative care in the nursing home Section 4: Healthcare professionals in palliative care 4.1: Dagny Faksvåg Haugen, Friedemann Nauck, and Deborah Witt Sherman: The core team and the extended team 4.2: Nathan I. Cherny, Batsheva Werman, and Michael Kearney: Burnout, compassion fatigue, and moral distress in palliative care 4.3: Betty R. Ferrell, Polly Mazanec, Pam Malloy, and Rose Virani: Nursing Education in palliative care 4.4: Terry Altilio, Bridget Sumser, and Nina Laing: Social work in palliative care 4.5: George Handzo and Christina Puchalski: The role of the chaplain in palliative care 4.6: Maria Denise Pessoa Silva, Fiona Rolls, Lynne White, Tamsin Longley, Jane Murphy, and Jill Cooper: Occupational therapy in palliative care 4.7: Nigel Hartley: The role of the creative arts in palliative care 4.8: Samantha Cushen and Aoife Ryan: The role of the dietitian in palliative care 4.9: Lucy Fettes and Matthew Maddocks: Physiotherapy in palliative care 4.10: Tim Luckett and Katherine L.P. Reid: Speech and language therapy in palliative care 4.11: E. Alessandra Strada: Clinical psychology in palliative care 4.12: Ebtesam Ahmed: The contribution of the clinical pharmacist in palliative care 4.13: Andrew M. Cole: Medical rehabilitation and the palliative care patient Section 5: Communication and palliative medicine 5.1: Thomas W. LeBlanc and James Tulsky: Communication with the patient and family 5.2: Susan D. Block: Practical considerations including difficult conversations 5.3: Judith Rietjens, Ida Korfage, and Jane Seymour: Advance care planning Section 6: Family and caregiver issues 6.1: Carrie Lethborg and David W. Kissane: Family dynamics in the context of serious illness 6.2: Rinat Nissim, Sarah Hales, and Gary Rodin: Caregiver burden and distress Section 7: Pain 7.1: Lucy N. Wyld, Clare Rayment, and Mike I. Bennett: Definition and assessment of chronic pain in advanced disease 7.2: Anthony H. Dickenson and Richard Gordon-Williams: Pathophysiology of pain in cancer and other terminal illnesses 7.3: Nathan I. Cherny: Acute cancer pain syndromes 7.4: Nathan I. Cherny: Chronic cancer pain syndromes 7.5: Ruth Miles, Steven Wanklyn, and Joy Ross: Principles of drug therapy 7.6: Nathan I. Cherny and Marie T. Fallon: Opioid therapy: optimizing analgesic outcomes 7.7: Joseph V. Pergolizzi, Jr., Jo Ann LeQuang, Flaminia Coluzzi, Dean Mariano, Andrew Nicolaou, and Christopher Gharibo: Opioid therapy: managing risks of abuse, addiction, and diversion 7.8: Per Sjøgren, Frank Elsner, and Stein Kaasa: Non-opioid analgesics 7.9: Russell K. Portenoy, Ebtesam Ahmed, and Mona Patel: Adjuvant analgesics: principles of use 7.10: Robert A. Swarm, Menelaos Karanikolas, Lesley K. Rao, and Rajiv K. Shah: Interventional approaches for chronic pain 7.11: Helena Knotkova: Neurostimulation in pain management 7.12: Joseph Winger, Carolyn E. Keeler, and Francis Keefe: Behavioral and psychosocial interventions for pain management 7.13: Noah Samuels and Eran Ben-Arye: Integrative medicine therapies in pain management 7.14: Peter Hoskin: Management issues in bone pain 7.15: Lise Ventzel and Nanna Finnerup: Management issues in neuropathic pain 7.16: Victor T. Chang: Management issues in visceral pain 7.17: Judith A. Paice: Management issues in chronic pain following cancer therapy 7.18: Renee McCulloch: Paediatric pain control Section 8: Gastrointestinal symptoms and disorders 8.1: Katherine Clark: Dysphagia, dyspepsia, and hiccups 8.2: Saskie Dorman: Nausea and vomiting 8.3: Philip J. Larkin: Constipation and diarrhoea 8.4: Alexandra Shingina and Anne M. Larson: Jaundice, ascites, and encephalopathy 8.5: Vickie Baracos and Sharon M. Watanabe: Aetiology, classification, assessment, and treatment of the anorexia-cachexia syndrome 8.6: Jann Arends and Florian Strasser: Parenteral nutrition Section 9: Cardio-respiratory symptoms and disorders 9.1: Miriam J. Johnson and David C. Currow: Breathlessness and other respiratory symptoms in palliative care 9.2: Doris Tse and Kin-Sang Chan: Cough and other pulmonary symptoms Section 10: Skin and oral symptoms and disorders 10.1: Sebastian Probst and Georgina Gethin: Skin problems in palliative care 10.2: Charles P. Tilley, Mei R. Fu, Janet H. Van Cleave, Allison R. Most, and Christopher Comfort: Palliative wound and ostomy care 10.3: Vaughan Keeley: Lymphoedema and oedema of advanced disease 10.4: Andrew N. Davies: Oral care Section 11: Genitourinary symptoms and disorders 11.1: Jennifer G. Rothschild, Noah E. Canvasser, Frederick J. Meyers, and Christopher Evans,: Dysuria, frequency, and bladder spasm 11.2: Noah E. Canvasser, Jennifer G. Rothschild, Frederick J. Meyers, and Christopher P. Evans: Obstructive urinary disorders Section 12: Constitutional symptoms and related disorders 12.1: Sriram Yennurajalingam and Eduardo Bruera: Fatigue 12.2: Lauren Kadwell, Jane Ussher, Emilee Gilbert, Janette Perz, and Amanda Hordern: Sexuality in palliative care: discussing patient sexuality and intimacy in palliative care 12.3: Kyriaki Mystakidou, Efi Parpa, and Eleni Tsilika: Sleep disorders 12.4: Simon Noble, Nicola Pease, and Nicholas Chinn-Yee: Assessment and management of thrombotic complications 12.5: Bill Hulme, Sarah Wilcox, Paul Ashwood, Laura Deacon, Hazel Gilkes, and Victoria Montgomery: Assessment and management of bleeding complications in the medically ill Section 13: Psychiatric and psychological symptoms and disorders 13.1: Tzeela Cohen and Simon Wein: Coping and resilience in palliative medicine 13.2: David W. Kissane: Depression, demoralization, and suicidality 13.3: Kerry A. Sherman and Christopher J. Kilby: Fear, anxiety, and adjustment disorder in palliative care 13.4: Meera Agar, Yesne Alici, Augusto Caraceni, and William Breitbart: Delirium 13.5: David W. Kissane: Bereavement Section 14: Palliative care in cancer 14.1: Nathan I. Cherny and Stein Kaasa: The oncologist s role in delivering palliative care 14.2: Olav Dajani and Karin Jordan: Disease-modifying therapies in advanced cancer-medical treatment 14.3: Peter Hoskin: Radiotherapy in symptom management 14.4: Robert Krouse and Brian Badgwell: The role of general surgery in the palliative care of patients with cancer 14.5: Mohamed Yakoub and John Healey: Orthopaedic surgery in the palliation of cancer 14.6: Eran Ben-Arye and Noah Samuels: Integrative oncology in palliative medicine 14.7: Tarun Sabharwal, Nicos I. Fotiadis, and Andy Adam: Interventional radiology in the palliation of cancer 14.8: Augusto Caraceni, Fabio Simonetti, and Cinzia Martini: Neurological problems in advanced cancer 14.9: Richella Ryan and Ruth Casey: Endocrine and metabolic complications of advanced cancer 14.10: Jason W. Boland and Elaine G. Boland: Malignant Bowel obstruction 14.11: Catriona R. Mayland and Simon N. Rogers: Palliative care issues in head and neck cancers 14.12: Thomas W. LeBlanc and Arjee El-Jawahri: Palliative care issues in populations with haematological malignancies 14.13: Nancy Zhu and Cynthia Wu: Anaemia, cytopenias, and thrombosis in palliative medicine Section 15: Issues in populations with non-cancer illnesses 15.1: Meera Pahuja and Peter Selwyn: HIV/AIDS 15.2: Natasha Smallwood and Nicole Goh: Advanced diseases of the lung 15.3: Steve Pantilat, Patricia Davidson, and Mitch Psotka: Advanced heart disease 15.4: Eric Widera, Shaida Talebreza, and Rachelle E. Bernacki: Dementia 15.5: Stefan Lorenzl and Raymond Voltz: Neurological disorders other than dementia 15.6: Arpan Patel and Anne Walling: Palliative care and end-stage liver disease 15.7: Fliss E.M. Murtagh: End-stage kidney disease 15.8: Anne Wilkinson and Marianne Matzo: Palliative care in catastrophic disasters and humanitarian crises Section 16: Issues of the very young and the very old 16.1: Erna Haraldsdottir and Sally Paul: Involving children and families when someone important is dying or has died 16.2: Myra Bluebond-Langner, Richard W. Langner, and Ignasi Clemente: Care of children with advanced illness 16.3: Meera Agar and Jane Phillips: Palliative medicine and care of the elderly Section 17: Spiritual issues in palliative medicine 17.1: Susan McClement, Genevieve Thompson, and Jamie Penner: Spiritual issues in palliative medicine 17.2: Yvan Beaussant, Alexandra Nichipor, and Tracy A. Balboni: Integration of spiritual care into palliative care service delivery models Section 18: The terminal phase 18.1: Christian T. Sinclair: Predicting survival in patients with advanced disease 18.2: David Hui and Masanori Mori: Physiology of dying 18.3: Judith Lacey and Nathan I. Cherny: Management of the actively dying patient Section 19: Ethical issues 19.1: Robert C. Macauley: Practical bioethics in the care of patients with advanced illness 19.2: Alexander A. Kon: Requests for futile or inappropriate interventions near the end of life 19.3: Nathan I. Cherny: Autonomy and shared decision making in a multi-cultural world 19.4: Linda Emanuel, Rebecca Johnson, and Lara Boyken: Truth-telling and consent 19.5: Richard D.W. Hain: Ethics in paediatric palliative care 19.6: Lars Johan Materstvedt: Ethical issues in physician aid-in-dying 19.7: Danielle Ko, Hannah Evans-Barns, and Craig Blinderman: Withholding and withdrawing life-sustaining treatment (including artificial nutrition and hydration) 19.8: Eric L. Krakauer: Medical and ethical considerations in palliative sedation at the end of life Section 20: Assessment tools and Informatics 20.1: Afaf Girgis, Amy Waller, and Breanne Hobden: Palliative care needs assessment tools 20.2: Jennifer Tieman and David C. Currow: Informatics and literature search 20.3: Madeline Li, Tracy A. Balboni, Rinat Nissim, and Gary Rodin: Validated assessment tools for psychological, spiritual, and family issues Section 21: Teaching and training in palliative medicine 21.1: Karen Forbes and Jane Gibbins: Physicians 21.2: Geana Paula Kurita and Philip J. Larkin: Nurses 21.3: Myra Glajchen, George Handzo, and Ebtesam Ahmed: Teaching and training in palliative social work, chaplaincy, and pharmacy Section 22: Research in palliative medicine 22.1: Marianne J. Hjermstad and Stein Kaasa: Research in palliative care 22.2: Miriam J. Johnson and David C. Currow: The principles of evidence-based medicine 22.3: Pål Klepstad and Stein Kaasa: Understanding clinical trials in palliative care research 22.4: Kate Flemming: Qualitative research 22.5: David K. Kissane, Christopher H. Grossman, and Clare O'Callaghan: Research into psychosocial issues 22.6: Tyler Tate and David Casarett: Ethical issues in palliative care research 22.7: Jon Håvard Loge and Stein Kaasa: Quality of life and patient-reported outcome measures 22.8: Tinne Smets and Luc Deliens: Health services research in palliative and end-of-life care 22.9: Irene J. Higginson and Mevhibe B. Hocaoglu: Clinical audit in palliative medicine

Read more less

Book SynopsisThe Oxford Handbook of Clinical Haematology provides core and concise information on the entire spectrum of blood disorders affecting both adults and children. Updated for its fourth edition, it includes all major advances in the specialty, including malignant haematology, haemato-oncology, coagulation, transfusion medicine, and red cell disorders, with a brand new chapter on rare diseases. Practically focused, and specifically designed for ease-of-use, and rapid access to the information you need, this handbook is an indispensable resource on all aspects of haematology for all trainee doctors, nurses, technicians, and research professionals.The handbook is divided into clinical approach and disease-specific areas. The clinical approach section outlines various symptoms and signs in patients with blood disease to enable the reader to formulate a sensible differential diagnosis beofre embarking on investigation and treatment. The disease-specific section is written by four authors whose expertise covers the whole breadth of diseases included in the book. All authors have contributed to national guidelines (e.g. British Committee for Standards in Haematology, BCSH) and are experts in the evidence base that exists for each topic. The Oxford Handbook of Clinical Haematology offers a concise and logical approach to caring for patients with diseases of the blood.Trade ReviewThis new edition follows the tradition of the highly respected Oxford medical handbook series which is a compact, well produced book brimming with knowledge that will help the clinician in a large number of situations. * Dr Harry Brown, glycosmedia.com *Table of Contents1. Clinical approach ; 2. Red cell disorders ; 3. White blood cell abnormalities ; 4. Leukaemia ; 5. Lymphoma ; 6. Myelodysplasia ; 7. Myeloproliferative neoplasms (MPNs) ; 8. Paraproteinaemias ; 9. Haematopoietic stem cell transplantation (SCT) ; 10. Haemostasis and thrombosis ; 11. Immunodeficiency ; 12. Paediatric haematology ; 13. Haematological emergencies ; 14. Supportive care ; 15. Protocols and procedures ; 16. Haematological investigations ; 17. Blood transfusion ; 18. Rare diseases ; A1 Haematology online ; A2 Charts and nomograms ; A3 Normal ranges

Read more less

Book SynopsisThe book addresses controversies related to the origins of cancer and provides solutions to cancer management and prevention. It expands upon Otto Warburg's well-known theory that all cancer is a disease of energy metabolism. However, Warburg did not link his theory to the "hallmarks of cancer" and thus his theory was discredited.Trade Review“This book offers a refreshing perspective for anyone wanting to get a comprehensive background on the newer emerging interest in targeting cancer metabolism for therapy.” (Doody’s, 11 January 2013) “For the first time, an entire issue is being devoted to a review article based on a recent medical book. This is a departure from our usual format, but I think you will agree that this topic warrants the detailed treatment we have given it . . .This book should be required reading for all scientifically literate people who are involved in the cancer problem.” (Advances in Cancer Treatment, 1 October 2012)Table of ContentsForword xiii Preface xv 1. Images of Cancer 1 How Cancer is Viewed 2 References 13 2. Confusion Surrounds the Origin of Cancer 15 The Oncogenic Paradox 18 Hallmarks of Cancer 18 Reassessment 26 References 27 3. Cancer Models 31 Problems with Some Cancer Models 31 Animal Charges as a Major Impediment to Cancer Research 38 Problems with Tumor Histological Classification 39 Personal Perspective on Cancer 44 References 45 4. Energetics of Normal Cells and Cancer Cells 47 Metabolic Homeostasis 47 The Constancy of the ∆G’ATP 54 ATP Production in Normal Cells and Tumor Cells 55 Energy Production Through Glucose Fermentation 57 Glutaminolysis with or without Lactate Production 61 Transamination Reactions 64 TCA Cycle, Substrate-Level Phosphorylation 66 Cholesterol Synthesis and Hypoxia 67 Summary 67 References 68 5. Respiratory Dysfunction in Cancer Cells 73 Normal Mitochondria 74 Morphological Defects in Tumor Cell Mitochondria 77 Proteomic Abnormalities in Tumor Cell Mitochondria 79 Lipidomic Abnormalities in Tumor Cell Mitochondria 81 Cardiolipin: A Mitochondrial-Specific Lipid 83 Cardiolipin and Abnormal Energy Metabolism in Tumor Cells 85 Complicating Influence of the In Vitro Growth Environment on Cardiolipin Composition and Energy Metabolism 92 Mitochondrial Uncoupling and Cancer 97 Cancer Cell Heat Production and Uncoupled Mitochondria 98 Personal Perspective 99 Summary 100 References 101 6. The Warburg Dispute 107 Sidney Weinhouse’s Criticisms of the Warburg Theory 108 Alan Aisenberg’s Criticisms of the Warburg Theory 110 Sidney Colowick’s Assessment of the Aisenberg Monograph 113 Apples and Oranges 114 References 116 7. Is Respiration Normal in Cancer Cells? 119 Pseudo-Respiration 119 How Strong is the Scientific Evidence Showing that Tumor Cells can Produce Energy Through OxPhos? 124 OxPhos Origin of ATP in Cancer Cells Reevaluated 124 What About OxPhos Expression in Other Tumors? 127 The Pedersen Review on Tumor Mitochondria and the Bioenergetics of Cancer Cells 128 References 129 8. Is Mitochondrial Glutamine Fermentation a Missing Link in the Metabolic Theory of Cancer? 133 Amino Acid Fermentation can Maintain Cellular Energy Homeostasis During Anoxia 133 Evidence Suggesting that Metastatic Mouse Cells Derive Energy from Glutamine Fermentation 134 Fermentation Energy Pathways can Drive Cancer Cell Viability Under Hypoxia 138 Competing Explanations for the Metabolic Origin of Cancer 141 Chapter Summary 143 References 143 9. Genes, Respiration, Viruses, and Cancer 145 Does Cancer have a Genetic Origin? 145 Respiratory Insufficiency as the Origin of Cancer 150 Germline Mutations, Damaged Respiration, and Cancer 154 Somatic Mutations and Cancer 158 Revisiting the Oncogene Theory 160 Mitochondrial Mutations and the Absence or Presence of Cancer 163 Viral Infection, Damaged Respiration, and the Origin of Cancer 165 Summary 168 References 168 10. Respiratory Insufficiency, the Retrograde Response, and the Origin of Cancer 177 The Retrograde (RTG) Response: An Epigenetic System Responsible for Nuclear Genomic Stability 177 Inflammation Injures Cellular Respiration 181 Hypoxia-Inducible Factor (HIF) Stability is Required for the Origin of Cancer 182 Mitochondria and the Mutator Phenotype 183 Calcium Homeostasis, Aneuploidy, and Mitochondrial Dysfunction 186 Mitochondrial Dysfunction and Loss of Heterozygosity (LOH) 187 Tissue Inflammation, Damaged Respiration, and Cancer 188 References 189 11. Mitochondria: The Ultimate Tumor Suppressor 195 Mitochondrial Suppression of Tumorigenicity 195 Normal Mitochondria Suppress Tumorigenesis in Cybrids 196 Evidence from rho0 Cells 198 Normal Mitochondria Suppress Tumorigenesis In Vivo 199 Normal Mouse Cytoplasm Suppresses Tumorigenic Phenotypes 200 Enhanced Differentiation and Suppressed Tumorigenicity in the Liver Microenvironment 202 Summary of Nuclear-Cytoplasmic Transfer Experiments 203 References 204 12. Abnormalities in Growth Control, Telomerase Activity, Apoptosis, and Angiogenesis Linked to Mitochondrial Dysfunction 207 Growth Signaling Abnormalities and Limitless Replicative Potential 208 Linking Telomerase Activity to Cellular Energy and Cancer 209 Evasion of Programmed Cell Death (Apoptosis) 209 Sustained Vascularity (Angiogenesis) 210 References 211 13. Metastasis 215 Metastasis Overview 215 Cellular Origin of Metastasis 217 Macrophages and Metastasis 221 Carcinoma of Unknown Primary Origin 232 Many Metastatic Cancers Express Multiple Macrophage Properties 233 Linking Metastasis to Mitochondrial Dysfunction 233 Revisiting the “Seed and Soil” Hypothesis of Metastasis 235 Revisiting the Mesenchymal Epithelial Transition (MET) 236 Genetic Heterogeneity in Cancer Metastases 237 Transmissible Metastatic Cancers 240 The Absence of Metastases in Crown-Gall Plant Tumors 240 Chapter Summary 241 References 241 14. Mitochondrial Respiratory Dysfunction and the Extrachromosomal Origin of Cancer 253 Connecting the Links 254 Addressing the Oncogenic Paradox 255 Is Cancer Many Diseases or a Singular Disease of Energy Metabolism? 258 References 258 15. Nothing in Cancer Biology Makes Sense Except in the Light of Evolution 261 Revisiting Growth Advantage of Tumor Cells, Mutations, and Evolution 262 Tumor Cell Fitness in Light of the Evolutionary Theory of Rick Potts 269 Cancer Development and Lamarckian Inheritance 271 Can Teleology Explain Cancer? 272 References 272 16. Cancer Treatment Strategies 277 Current Status of Cancer Treatment 277 The “Standard of Care” for Glioblastoma Management 280 References 285 17. Metabolic Management of Cancer 291 Is it Dietary Content or Dietary Composition that Primarily Reduces Tumor Growth? 292 Dietary Energy Reduction and Therapeutic Fasting in Rodents and Humans 294 Ketogenic Diets 295 Glucagon and Insulin 297 Basal Metabolic Rate 298 Ketones and Glucose 298 Metabolic Management of Brain Cancer Using the KD 299 Glucose Accelerates Tumor Growth! 301 Glucose Regulates Blood Levels of Insulin and Insulin-Like Growth Factor 1 302 Dietary Energy Reduction is Antiangiogenic 302 Dietary Energy Reduction Targets Abnormal Tumor Vessels 307 Dietary Energy Reduction is Proapoptotic 309 Dietary Energy Reduction is Anti-Inflammatory 310 Targeting Energy Metabolism in Advanced Cancer 314 Differential Response of Normal Cells and Tumor Cells to Energy Stress 316 Dietary Energy Reduction is Anti-Invasive in Experimental Glioblastoma 318 Influence of Growth Site and Host on Tumor Progression 322 Implications of Dietary Energy Reduction for Anticancer Therapeutics 324 Targeting Glucose 325 Metformin 326 Synergistic Interaction of the Restricted Ketogenic Diet (KD-R) and 2-Deoxyglucose (2-DG) 327 Can Synergy Occur with the KD-R and Hyperbaric Oxygen Therapy? 331 Targeting Glutamine 333 Glutamine Targeting Inhibits Systemic Metastasis 334 Targeting Phagocytosis 339 Targeting the Microenvironment 340 Dietary Energy Reduction as a Mitochondrial Enhancement Therapy (MET) 341 Summary 341 References 341 18. Patient Implementation of Metabolic Therapies for Cancer Management 355 Introduction 355 Guidelines for Implementing the Restricted Ketogenic Diet as a Treatment Strategy for Cancer 356 Complicating Issues for Implementing the KD-R as a Treatment Strategy for Cancer 366 Radiation and Chemotherapy is a Standard Treatment for Many Malignant Cancers 366 Compliance 367 Cancer as a Genetic Disease 367 Mechanism of Action? 368 Cachexia 368 Summary 369 References 370 19. Cancer Prevention 375 Cell Phones and Cancer 376 Alzheimer’s Disease and Cancer Risk 377 Ketone Metabolism Reduces Cancer Risk 378 Mitochondrial Enhancement Therapy 379 Therapeutic Fasting and Cancer Prevention 379 Autophagy and Autolytic Cannibalism: A Thermodynamic Approach to Cancer Prevention 381 Cancer Prevention by Following Restricted Ketogenic Diet 382 References 384 20. Case Studies and Personal Experiences in Using the Ketogenic Diet for Cancer Management 387 Effects of a Ketogenic Diet on Tumor Metabolism and Nutritional Status in Pediatric Oncology Patients: Comments from Dr. Linda Nebeling 387 Raffi’s Story: Comments from Miriam Kalamian 389 Biological Plausibility that Cancer is a Metabolic Disease Dependent for Growth on Glucose and Glutamine: Comments from Dr. Bomar Herrin 395 Using the Restricted Ketogenic Diet for Brain Cancer Management: Comments from Neuro-Oncologist, Dr. Kraig Moore 397 The Ketogenic Diet for Brain Cancer Management: Comments from Beth Zupec-Kania 400 Summary 402 References 403 21. Conclusions 405 Major Conclusions 407 References 408 Index 409

Read more less

Book Synopsis150 recipes that meet the unique and specialized nutritional needs for individuals undergoing cancer treatment.

Read more less

Book SynopsisSoft tissue tumours are extremely common although difficult to understand due to a large number of sub-types, leading to a significant increase in their imaging in the last decade. This highly illustrated practical book provides a simplified, systematic approach to imaging, reporting and diagnosing these tumours. It covers all the modalities with emphasis on ultrasound and MRI, along with the newer techniques in these modalities. This concise guide to soft tissue lesions, will help clinicians to quickly understand the spectrum of tumours and identify the appropriate imaging techniques to best serve their patients.Key Features: Provides guidance by international experts on various types of soft tissue tumours (benign, malignant and tumour mimics), their relevant imaging features to help suggest specific or differential diagnosis and when to biopsy and when to refer to specialist centres Proves to be an excellent resource for general and specialist radiologisTable of ContentsPreface. Acknowledgements. About the editors. List of contributors. Approach to soft tissue lesions. Imaging modalities and techniques in soft tissue tumours. Lipomatous tumours. Fibroblastic, myofibroblastic and fibrohistiocytic tumours. Peripheral nerve tumours. Synovial pathologies. Muscle tumours. Vascular tumours. Tumours of uncertain origin. Other non-sarcomatous soft tissue tumours. Soft tissue tumour mimics. Biopsy of soft tissue tumours. Histopathology of soft tissue lesions. Imaging of post-treatment changes in soft tissue sarcomas. Index.

Read more less

Book Synopsis

Read more less

Book SynopsisThis book discusses the scope and limitations of complex reconstructive surgery that few Plastic Surgeons master, and that the public rarely encounters, portraying both the technical challenges of advanced reconstructive microsurgery and the human connection between physician and patient as only a master surgeon can convey.For decades, Dr. Deleyiannis has practiced one of the most demanding fields of surgery, treating patients with highly complex and devastating deformities from cancer, trauma, and birth anomalies. Laying the historical foundation of scientific discoveries upon which modern microsurgical practice is based, he takes us âœbehind the scenesâ with real patientsâ stories, highlighting surgical innovation in his own career and the impact on the lives of those he treats.Plastic surgeons and surgeons specialising in reconstruction techniques for patients who have suffered either trauma or cancer will find inspiration and renewed dedication for their specialism

Read more less

Book SynopsisThis popular textbook provides a clear and comprehensive introduction to the principles and practice of clinical oncology. Ideal for medical undergraduates, clinicians and other health professionals who want to increase their understanding of the challenges of managing patients with cancer, the book enables readers to learn and then test themselves on all aspects of cancer medicine, from epidemiology, aetiology, pathogenesis and presentation, through to diagnosis, staging, management and prognosis. Table of ContentsPathogenesis of cancer. Principles of cancer diagnosis and staging. Decision-making and communication. Principles of surgical oncology. Principles of radiotherapy. Principles of systemic treatment. Lung cancer and mesothelioma. Breast cancer. Gastrointestinal cancer. Urological cancer. Gynaecological cancer. CNS tumours. Head and neck cancer. Endocrine tumours. Sarcomas. Lymphoma. Haematological malignancy. Paediatric cancer. Skin cancer. Carcinoma of unknown primary. Oncological emergencies. Palliative care. Appendix 1: Worldwide cancer burden – males and females. Appendix 2: Worldwide cancer burden – males. Appendix 3: Worldwide cancer burden – females. Appendix 4: Answers to self-assessment questions

Read more less

Book Synopsis''Once treatment stops, and people leave strictly managed clinical environments, survivors feel as though they had fallen off a cliff edge... feeling isolated and abandoned at a time when support is needed the most''. - Mental Health Foundation From the final infusion to the five-year check, After Breast Cancer gives a step-by-step support package to coping post-treatment. It follows on from Sara Liyanage''s successful coverage of diagnosis and treatment in Ticking Off Breast Cancer, and is driven not only by her experience of illness, but underpinned by contributions from leading oncologists, heads of cancer services, and clinical consultant psychologists. With a readable blend of informality and medically endorsed insight, After Breast Cancer has an optimistic outlook and a reassuring tone, but doesn''t flinch from discussing the possibility of secondary cancer, or the full impact of treatment and surgery on you or your loved oneTrade ReviewThis is a wonderfully helpful, sensible guide for anyone navigating the challenges of life after breast cancer treatment. -- Victoria DerbyshireSara has done it again. This brilliant book shows you how to cope with the physical, mental and emotional impact of an early breast cancer diagnosis. A must-read for you and your family. -- Dr Liz O'RiordanA brilliant and practical book for those navigating life after primary breast cancer. -- Dr Anisha PatelThis great book gives a wonderfully comprehensive range of practical and emotional strategies to help you cope when the treatment ends - Sara holds your hand into the next stage of your life, after breast cancer. -- Dr Zoe WilliamsA cancer diagnosis leaves you irrevocably changed. Whatever the outcome, life will be different and there is no going back. Sara recognises this - not least through her own lived experience - and After Breast Cancer is her offering to all those facing this challenge. This is a compassionate guide - meticulously researched and sensitively written - for anyone wondering how best to navigate life after the Big C. A perfect mixture of hope, realism and practical tips, After Breast Cancer will be a valuable resource for so many. -- Dr Hannah Short, Co-author of 'The Complete Guide to POI and Early Menopause''This book is honest and open and full of practical advice, coping mechanisms and tools. It is an essential resource for those embarking on life after cancer and we highly recommend it. Well done Sara and everyone involved in creating this much-needed book. -- Stephanie Davies, founder of Life After Cancer, ICF trained coach and NLP practitioner

Read more less

Book Synopsis... Useful background information is displayed in blue boxes, and good use is made of numerous tables and diagrams... a useful book for the undergraduate medical or allied health professional... Oncology News, May/June 2010 This forward looking cancer biology book appeals to a wide ranging audience. Introductory chapters that provide the molecular, cellular, and genetic information needed to comprehend the material of the subsequent chapters bring unprepared students up to speed for the rest of the book and serve as a useful refresher for those with previous biology background. The second set of chapters focuses on the main cancers in terms of risk factors, diagnostic and treatment methods and relevant current research. The final section encompasses the immune system's role in the prevention and development of cancer and the impact that the Human Genome Project will have on future approaches to cancer care. While best suited to non-majors cancer biology coursesTrade Review"In summary, this is a useful book for the undergraduate medical or allied professions." (Oncology News, June 2010) “The style of writing is very clear. Questions are posed to the reader promoting thought and greater understanding of the text. Useful information is displayed in blue boxes and good use is made of numerous tables and diagrams.” Dr Karin Baria, Onocology News, 2010Table of ContentsPreface. Acknowledgements. 1. The Basics of Cancer. Cancer is a Complex Entity. Cancer Through the Ages. Modern Day Cancer Research and Treatment. Prevalence and Mortality Varies With Each Cancer. Risk Factors Have Been Identified. Will Cancer be Conquered Within Our Lifetime? 2. Cells: the Fundamental Unit of Life. Seven Hierarchal Levels of Organization. Four Types of Macromolecular Polymers. Cell Structure and Function. Relationship Between Structure and Function is Important. 3. The Human Genome and Protein Function. The Composition and Function of the Human Genome. Having a Diploid Genome has its Advantages. Proteins Carry Out Diverse Functions. 4. Cell Cycle, Oncogenes, and Tumor Suppressor Genes. Cell Division in Germ-line and Somatic Tissues. Consequences of Germ-line and Somatic Tissue Mutations. Cell Division, Differentiation, and Maturation Occur to Form Functional Tissues. Cell Division is Under the Regulation of the Cell Cycle. Loss of Cell Cycle Control Results in Uncontrolled Cell Growth. 5. Tumor Formation, Growth, and Metastasis. Tissue Changes that Occur in Response to Stimuli. Feeding Tumor Growth by Angiogenesis. Characteristics of Benign and Malignant Tumors. Events that Occur During the Process of Metastasis. 6. Cancer Screening, Detection and Diagnostic Procedures and Tests. Factors that Determine the Accuracy of a Diagnostic Test or Procedure. Common Screening Tests. Diagnostic Procedures for the Confirmation of a Disease. Tumor Grade and Stage Factors into the Type of Treatment Regimen and Prognosis. 7. Cancer Treatment Modalities. Surgery: the Oldest and Most Commonly Used Treatment Method. Radiation Kills by Causing Extensive DNA Damage. Cytotoxic Effects of Chemotherapeutic Drugs. Side Effects and Risks From the Use of Cytotoxic Drugs. Hormonal Deprivation Treatment: Used for Estrogen- and Androgen-dependent Cancers. Can Cancer Growth be Controlled by Inhibiting Angiogenesis? Additional Enzymes Targeted for Inhibition. Biological Therapy Stimulates the Body’s Ability to Fight Cancer. 8. Breast Cancer. Breast Cancer Statistics. Women’s Breast Tissue: Unique in Structure and Function. Causes of Breast Cancer. Regular Examinations of the Breast are Important for Early Diagnosis. What Follows a Positive Diagnosis? Treatment Options are Unique for Each Individual. Much has Been Accomplished, More Needs to be Done. 9. Ovarian Cancer. Ovarian Cancer Statistics. Structure and Function of Ovaries. There are Three Tissue Categories of Ovarian Cancer. Symptoms are Vague and Often Missed. Certain Factors Have Been Associated with a Higher Risk. Diagnostic Tools are Available But Not Always Used or Recommended. Additional Procedures are Necessary to Confirm Suspicious Results or if there is Metastasis. The FIGO System May be Used to Stage Ovarian Cancer. Treatment Options for Ovarian Cancer. Steps are Taken to Prevent Recurrence But Do Not Always Work When the Cancer is Advanced. Much Needs to be Done in the Future. 10. Cervical Cancer. Cervical Cancer Statistics. Structure and Function of the Cervix. Symptoms of Cervical Cancer. Pelvic Examinations and Pap Tests Enable Early Detection. Risk Factors for Cervical Cancer. The HPV Test is a Vital Diagnostic Tool. Additional Tests are Necessary to Examine the Cervix. Treatment Depends on the Stage. A Vaccine will Prevent Many Cases of Cervical Cancer. 11. Prostate Cancer. Prostate Cancer Statistics. Function of the Prostate Gland. Certain Factors Influence the Development of Prostate Cancer. Symptoms of an Enlarged Prostate. Screening and Diagnostic Tests for Prostate Cancer. There are Traditional and Unique Treatment Options Available. Prostate Cancer Mortality Rates Have Decreased. Much Attention is being Given to the Number One Cancer Affecting Men. 12. Testicular Cancer. Testicular Cancer Statistics. Structure and Function of Testicles. There are Three Types of Testicular Tumors. Risk Factors for the Disease. Symptoms of Testicular Cancer. Testicular Self-examination (TSE) is Recommended. Blood and Imaging Tests are Used to Determine Diagnosis and Possible Metastasis. Testicular Cancer Treatment Results in a High Cure Rate. Causes and Treatments are being Studied. 13. Skin Cancer. Skin Cancer Statistics. Structure and Function of the Skin. Three Types of Skin Cancer. Risk Factors for Developing Skin Cancer. Methods Used to Screen for Skin Cancer. Surgery and Chemotherapy are Standard Treatments for Metastatic Skin Cancer. What Happens After Skin Cancer Treatment. Limited UV Radiation Exposure is the Number One Form of Prevention. 14. Lung Cancer. Lung Cancer Statistics. Lungs are the Site of the Exchange of Gases. Risk Factors Associated with the Development of Lung Cancer. Lack of Distinctive Symptoms Makes Early Diagnosis Difficult. Lung Cancer is Often Diagnosed at an Advanced Stage. There are Two Main Categories of Lung Cancer. Three Traditional Therapies are Used in Lung Cancer Treatment. Is There Discrimination in Cancer Research Funding? 15. Colorectal Cancer. Colon and Rectum are the Last Two Sections of the Gastrointestinal Tract. Risk Factors for Colorectal Cancer. Screening Tests. Treatment Options. Targeted Therapies. Screening Tests Performed After the Course of Treatment. 16. Leukemia and Lymphoma. Leukemia Statistics. Leukemia is a Cancer of the Blood Cells. The Exact Cause of Leukemia is Unknown. Early Symptoms of Leukemia. Laboratory Studies are Necessary to Determine the Diagnosis. There are Many Types of Leukemia. Nonchemotherapeutic Options have Significantly Improved Survival Rates. Lymphoma is a Malignancy of the Lymphatic System. Hodgkin’s vs. Non-Hodgkin’s lymphoma. Certain Risk Factors are Associated with an Increased Incidence of Lymphoma. Diagnosing Lymphoma Involves Biopsies and Imaging Tests. Lymphomas Must be Classified to Determine Appropriate Treatment. Treatment Options Depend on the Type of Lymphoma, Stage, and Extent of Metastasis. Glossary. Index. Companion website www.wiley.com/go/almeida/cancer

Read more less

Book SynopsisA NEW YORK TIMES BESTSELLERThe inspiring story of a son and his dying mother, who form a 'book club' that brings them together as her life comes to a close.Trade ReviewWill Schwalbe gives us two love stories in one: That of his relationship with his dynamo of a mother as her horizons shrink, and that of their mutual devotion to the printed word, infinitely and insistently engaging. Tender and touching and beautifully done. * Stacy Schiff, Pulitzer Prize winning author of Cleopatra *I was so moved by this marvellous book. Schwalbe has done something extraordinary: made a personal journey public in the most engaging, funny and revealing way possible. It is a true meditation on what books can do. * Edmund de Waal, author of The Hare with Amber Eyes *A perfect book-club book about books and the community they create that also portrays the love between mother and son. * Library Journal *Will Schwalbe's brave and soulful elegy to his remarkable mother, his recollection of their sparklingly literate conversations, is a timely reminder that one exceptional person, or one exceptional book, can be a torch in the darkness. You'll turn the last page wishing you'd met Mary Anne Schwalbe, vowing to be worthy of her incandescent example - and promising yourself to read more. * J. R. Moehringer, author of The Tender Bar *At last a book that celebrates the role books play within our own story. Will Schwalbe has created a tender, moving and honest portrayal of the precious relationship between a mother and son - an ode to that beautiful thing called love. * Cecilia Ahern, author of PS, I Love You *A wonderful book about wonderful books and mothers and sons and the enduring braid between them. Like the printed volumes it celebrates, this story will stay with you long after the last page. * Mitch Albom, author of Tuesdays With Morrie and The Time Keeper *an astonishing, pertinent, and wonderfully welcome work. * Publishers Weekly starred review *An extraordinarily wise, witty, and quietly wrenching book about parental love, filial love, profound grief, and literature's great consolations. How wonderful to encounter a writer who combines erudition with great emotional honesty, and who isn't afraid of addressing life's most profound and baffling questions. * Douglas Kennedy, author of Leaving the World and The Pursuit of Happiness *a moving and inspiring story * Choice Magazine *This touching and insightful memoir about the slow process of dying will appeal to readers of Tuesdays With Morrie and The Last Lecture, but also to people who love delving into books and book discussions. Like Mary Anne, who reads the ending first, you know how this book is going to end, but while it is a story about death, it is mostly a celebration of life and of the way books can enrich it. * Booklist (starred review) *What self-respecting reader isn't a sucker for a great book about other great books? The End of Your Life Book Club is that much and more. * BookPage *a graceful, affecting testament to a mother and a life well lived. * Entertainment Weekly *Literature bridges generations in Will Schwalbe's thoughtful tribute to his late mother * Vogue.com *a tribute to a remarkable woman and an exemplary reader. * Salon *A truly poignant read . . . a moving tribute to a wonderful-sounding mum and the power of fiction. * Good Housekeeping *It helps of course if you are a book lover and can relate to the passion for reading, but even prolific readers will find that the book teaches them not only about life and death but about the power of a really good book to move you and peel off the onion skin layers of "what you already know" and reveal truths. * Curious Book Fans *a life-enhancing celebration of the power of books and reading, very much in the vein of Tuesdays with Morrie * Independent *

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book SynopsisCancer can make you feel powerless. Survival rate statistics can leave you feeling helpless and afraid. But you are a person, not a percentage. And you are not powerless. In Help Heal Yourself from Cancer, cancer survivors and medical-profession veterans Bill and Martha Sears help you go from patient to partner in your cancer-healing journey. They outline the steps you can take, both in working with your cancer-care providers and on your own, to maximize your chances of not just beating cancer, but thriving in its wake. This comprehensive guide will help you: Develop a conquer-cancer mindset. The science is clear: cancer healing begins with the brain. Believing you will heal is the first step. Personalize your treatment plan. Find out what tests to ask for, which advice to pay attention to (and what to ignore), and how to talk to your oncologist about designing a plan that’s perfectly tailored to you and your cancer. LEAN in to supporting your immune system. Learn how to best support your natural cancer-fighting army through lifestyle, exercise, and nutrition — giving chemotherapy and radiation the best chance of success. With eye-catching illustrations to boost understanding and special sections on breast, colon, lung, and brain cancers, this book gives you the tools you need to stop fearing your cancer and start boosting your immune system, fine-tuning your treatment plan, and taking charge of your healing — all so you can ultimately Help Heal Yourself from Cancer.

Read more less

Bowel cancer, despite being the UK’s second biggest cancer killer, still receives a shockingly low level of awareness. This book aims to redress this by telling the story of a mother of two who embarked on a crash course dealing with advanced bowel cancer at the age of 45. Having absolutely no preparation, her lists help her gain control over what fast becomes an even more chaotic and unpredictable life. Her diagnosis presents a wake-up call to what’s important in life, and insists that daft and often funny things can still happen to people living with cancer. This is a memoir packed full of useful advice for making the best of your sudden situation – from learning how to deal with your new menagerie of medics to how to avoid all the usual cancer faux pas! As someone who describes herself as habitually “not doing today what I can put off till tomorrow”, Rachel shares with you all the lists you need to cope with gaining back some control from the chaos. This is the ultimate reader-friendly guide on how to deal with operation after operation, the reality of chemotherapy and, when that’s over, how to function on a daily basis with your ‘new normal’. But most importantly, it’s a record of how Rachel taught her children resilience, her number one challenge in life.

Read more less

Book SynopsisWhen my blood became ink, words began to flow.

Read more less

Book SynopsisThis bang up-to-date new book is the absolutely key guide to how to get the best possible cancer care. What you do can make an enormous difference to your care. / This can quite literally be a matter of life or death. With this book You can navigate the medical maze. / The book tells you what the NHS doesn''t tell you, but which you need to know It puts key expertise into your own hands - to make the system work for you.

Read more less

Book SynopsisThis textbook discusses the systemic consequences of cancer, covering a range of topics from tumor-promoting systemic effects to the development of cachexia, as summarized in the introductory chapter 1. Part I of this textbook focuses on tumor-promoting systemic effects and begins with a chapter on how tumor-derived extracellular vesicles and particles lay the foundation for future metastases (Chapter 2). Chapter 3 discusses how metastatic cells that have colonized the bone impact the local bone microenvironment, neighboring muscles, and host physiology. Chapter 4 summarizes the available strategies for targeting metastatic cancer and emphasizes the need to incorporate a systemic view of the disease. Following this overview of the systemic effects of cancer progression, Part II of the textbook discusses cancer-induced cachexia, a debilitating systemic effect of advanced cancer. Chapters 5-7 examine the key signaling pathways (interleukin-6/GP130, NF-kB, and muscle proteolysis) that drive the development of cancer cachexia. Chapters 8 and 9 in Part III of this textbook explore how toxicities from anti-cancer therapy are associated with the onset of cachexia in cancer patients, and provide insight into potential approaches to simultaneously target both cancer and cachexia. Chapters 10 and 11 (Part IV) conclude this textbook by outlining promising approaches for the diagnosis and treatment of cachexia as well as strategies to prevent the development of cachexia through exercise. An understanding of the systemic effects of cancer is essential for the design of effective anti-cancer and anti-cachexia treatment strategies. As such, this textbook provides key information for both students and scientists engaged in cancer research and oncology.Table of ContentsChapter 1: A systemic view of metastatic disease: inter-organ crosstalk and therapeutic implicationsPART I - Systemic Regulation in Metastatic DiseaseChapter 2: Systemic Regulation of Metastatic Disease by Extracellular Vesicles and ParticlesChapter 3: Bone Metastasis: Systemic Regulation and Impact on HostChapter 4: Targeting Metastatic Disease: Challenges and New OpportunitiesPART II - Cachexia: a Debilitating Systemic Effect of CancerChapter 5: Signaling Pathways That Promote Muscle Catabolism in CachexiaChapter 6: The Role of Interleukin-6 Cytokines in Cancer CachexiaChapter 7: NF-kB Signaling in the Macroenvironment of Cancer CachexiaPART III - Therapy-induced Muscle WastingChapter 8: Therapy-Induced Toxicities Associated With the Onset of CachexiaChapter 9: Bone-muscle Crosstalk in Advanced Cancer and ChemotherapyPART IV - Preventing and Targeting Cachexia in CancerChapter 10: New Developments in Targeting Cancer CachexiaChapter 11: Exercise: A Critical Component of Cachexia Prevention and Therapy in Cancer

Read more less

Book SynopsisThe Third Edition of Handbook of Evidence-Based Radiation Oncology updates and revises the previous successful editions and serves as a key reference for radiation oncology professionals. Organized by body site, concise clinical chapters provide easy access to critical information. Important "pearls" of epidemiology, anatomy, pathology, and clinical presentation are highlighted. The key elements of the work-up are listed, followed by staging and/or risk classification systems. Treatment recommendations are discussed based on stage, histology, and/or risk classification. Brief summaries of key trials and studies provide the rationale for the recommendations. Practical guidelines for radiation techniques are described and complications and follow-up guidelines are outlined. The Third Edition incorporates new key studies and trials to reflect current radiation oncology practice; includes the most recent staging systems; and features new color illustrations and anatomic atlases to aid in treatment planning. This book is a valuable resource for students, resident physicians, fellows, and other practitioners of radiation oncology. Trade Review“Nearly a thousand pages in length, this handbook provides a detailed yet bulleted review of the practice of clinical radiation oncology. … The intended audience is residents and practicing radiation oncologists. The clinical focus of the book will be of benefit to those seeking to identify and understand best clinical practice in radiation oncology.” (Mark D. Hurwitz, Doody's Book Reviews, October, 2018)This textbook provides a concise and well-organized approach to the workup, staging, and treatment of the wide range of cancers and non-malignant conditions treated by radiation oncologists. … This edition of the Handbook of Evidence-Based Radiation Oncology is a welcomed update given its expansive knowledge base and succinct summary of new radiation oncology-related evidence.” (Jim Zhong, Neurosurgery, Vol. 84 (3), March, 2019)Table of ContentsSkin Cancer.- Central Nervous System.- Malignant and Benign Diseases of the Eye and Orbit.- Cancer of the Ear.- Nasopharyngeal Cancer.- Nasal Cavity and Paranasal Sinus Cancer.- Oropharyngeal Cancer.- Cancer of the Lip and Oral Cavity.- Larynx and Hypopharynx Cancer.- Salivary Gland Tumors.- Thyroid Cancer.- Unusual Neoplasms of the Head and Neck.- Management of the Neck and Unknown Primary of the Head and Neck.- Small Cell Lung Cancer.- Non-small Cell Lung Cancer.- Mesothelioma and Thymic Tumors.- Breast Cancer.- Esophageal Cancer.- Gastric Cancer.- Pancreatic Cancer.- Hepatobiliary Cancer.- Colorectal Cancer.- Anal Cancer.- Renal Cell Carcinoma.- Bladder Cancer.- Prostate Cancer.- Cancer of the Penis.- Testicular Cancer.- Cervical Cancer.- Endometrial Cancer.- Ovarian Cancer.- Vaginal Cancer.- Vulvar Cancer.- Urethral Cancer.- Hodgkin’s Lymphoma.- Non-Hodgkin’s Lymphoma.- Cutaneous Lymphomas.- Multiple Myeloma and Plasmacytoma.- Bone Tumors.- Soft-Tissue Sarcoma.- Pediatric (Non-CNS) Tumors.- Palliation and Benign Conditions.- Clinical Radiobiology and Physics.

Read more less

Book SynopsisA masterful synchronization of history and cutting-edge science shines new light on humanity's darkest diagnosis. Over 50,000 copies sold! "Tripping over the Truth will have profound consequences for how cancer is managed and prevented."—Thomas N. Seyfried, author of Cancer as a Metabolic Disease In the wake of the Cancer Genome Atlas project's failure to provide a legible roadmap to a cure for cancer, science writer Travis Christofferson illuminates a promising blend of old and new perspectives on the disease. Tripping over the Truth follows the story of cancer’s proposed metabolic origin from the vaunted halls of the German scientific golden age to modern laboratories around the world. The reader is taken on a journey through time and science that results in an unlikely connecting of the dots with profound therapeutic implications. Transporting us on a rich narrative of humanity’s struggle to understand the cellular events that conspire to form malignancy, Tripping over the Truth reads like a detective novel, full of twists and cover-ups, blind-alleys and striking moments of discovery by men and women with uncommon vision, grit, and fortitude. Ultimately, Christofferson arrives at a conclusion that challenges everything we thought we knew about the disease, suggesting the reason for the failed war against cancer stems from a flawed paradigm that categorizes cancer as an exclusively genetic disease. For anyone affected by this terrifying disease and the physicians who struggle to treat it, this book provides a fresh and hopeful perspective. It explores the new and exciting non-toxic therapies born from the emerging metabolic theory of cancer. These therapies may one day prove to be a turning point in the struggle against our ancient enemy. We are shown how the metabolic theory redraws the battle map, directing researchers to approach cancer treatment from a different angle, framing it more like a gentle rehabilitation rather than all-out combat. In a sharp departure from the current “targeted” revolution occurring in cancer pharmaceuticals, the metabolic therapies highlighted have one striking feature that sets them apart—the potential to treat all types of cancer because they exploit the one weakness that is common to every cancer cell: dysfunctional metabolism. With a foreword by Dr. Dominic D'Agostino, PhD and contributions from Thomas Seyfried, PhD, author of Cancer as a Metabolic Disease; Miriam Kalamian, EdM, MS, CNS, author of Keto for Cancer; and Beth Zupec Kania, consultant nutritionist of The Charlie Foundation. "Brilliant, timely, and expertly consolidated . . . It reads like a novel and is easy to comprehend for everyone interested in the new conversation around cancer and cancer care. I recommend it to patients, family, friends, and colleagues and refer back to it often.”—Dr. Nasha Winters, ND, coauthor of The Metabolic Approach to CancerTrade Review"Travis Christofferson provides a compelling historical account of how cancer has been misunderstood as a genetic disease when, in fact, it is a type of metabolic disease. Unlike normal cells, which obtain their energy from respiration, cancer cells have damaged respiration and obtain much of their energy from the primitive process of fermentation. Travis describes how the mutations in tumors arise as an effect of respiratory damage and cannot be the cause or drivers of cancer. The information presented in Tripping over the Truth will have profound consequences for how cancer is managed and prevented. Metabolic therapies will be more effective and less toxic than the current gene- or immune-based therapies and have the potential to significantly improve quality of life and long-term survival for millions of cancer patients worldwide.”--Thomas N. Seyfried, PhD, author of Cancer as a Metabolic Disease“I absolutely loved Dr. Seyfried’s book, Cancer as a Metabolic Disease, and Dr. Mukherjee’s book, The Emperor of all Maladies, but it was difficult to get my patients to read these two books to understand the history of cancer and the cancer industry, not to mention the movement from the somatic to the metabolic theory of cancer, both intimidating subjects. Then, along came Travis Christofferson’s brilliant, timely, and expertly consolidated book. It reads like a novel and is easy to comprehend for everyone interested in the new conversation around cancer and cancer care. I recommend it to patients, family, friends, and colleagues and refer back to it often.”--Dr. Nasha Winters, ND, coauthor of The Metabolic Approach to Cancer“Phenomenal…required reading for anyone who has cancer or knows someone who has cancer…I cannot stress its importance enough. Get yourself a copy, and read it.”--Dr. Joseph Mercola, founder and director, mercola.com“The author takes us on over a hundred-year exciting journey of the research to understand and eradicate this disease…This is a great scientific mystery book…This book is for everyone, but should be read by all physicians that treat cancer. I congratulate the author for a marvelous job and highly recommend this book.”--Robert L. Elliot, MD, PhD“An iconoclastic, information-rich narrative that boldly challenges our current understanding and treatment of cancer. Christofferson persuasively argues and documents why a restricted calorie, high (good) fat diet should at least be considered for most malignancies. An absolute must-read to understand the history and evolution of present day cancer therapy.”--Joseph C. Maroon, MD, Author of The Longevity Factor

Read more less

Book SynopsisTable of ContentsPreface Acknowledgements 1 Cells, Tissues and Cancer 2 Blood Cancers 3 Sarcoma 4 The Nervous System - Brain Tumours 5 The Endocrine System 6 Head and Neck Cancer 7 Digestive System Tumours 8 Urinary System Tumours 9 The Male Reproductive System 10 The Female Reproductive System 11 Lung Cancer 12 Skin Cancer Index

Read more less

Book SynopsisPocket-sized and easy to use, Pocket Oncology, 3rd Edition, provides up-to-date information essential to caring for patients with cancer, from cancer biology, prevention, screening, treatment, and supportive care to new advances in all areas of the field for both adult and pediatric patients. Written and edited by leading cancer experts at Memorial Sloan Kettering Cancer Center, this unique, loose-leaf resource is designed for portability and quick reference, with information presented in a bulleted, outline format throughout. Includes new information on CAR-T cell therapy, immunotherapy, precision medicine, and other recent medical oncology treatments and therapies Includes new and updated sections on recently approved oncologic therapies, benign hematology, pediatrics, surgical oncology, interventional radiology, radiation oncology, and telehealth Presents information on adult and pediatric oncologic diseases with coverage of initial clinical presentation, pathophysiology, staging, current standards of care treatments, and active areas of current research Follows the popular Pocket Notebook format, featuring bulleted lists, tables, diagrams, and algorithms that make essential facts easy to find and retain Contains helpful appendices on radiographic response criteria, quality of life assessments, tumor markers, and more, plus a section of clinically essential color photos Ideal as a pocket reference for daily practice as well as an accepted and trusted resource for trainees and other members of the oncology care team

Read more less

Book SynopsisThis major reference work is the most comprehensive resource on oncologic critical care. The text reviews all significant aspects of oncologic ICU practices, with a particular focus on challenges encountered in the diagnosis and management of the critically ill cancer patient population. Comprised of over 140 chapters, the text explores such topics as the organization and management of an oncologic ICU, diseases and complications encountered in the oncologic ICU, multidisciplinary care, surgical care, transfusion medicine, special patient populations, critical care procedures, ethics, pain management, and palliative care. Written by worldwide experts in the field, Oncologic Critical Care is a valuable resource for intensivists, advance practice providers, nurses, and other healthcare providers, that will help close significant knowledge and educational gaps within the realm of medical care for critically ill cancer patients.Table of ContentsPart 1. Organization and Management of an Oncologic Critical Care Unit1. Oncologic Critical Care Department Organization 2. Critical Care Staffing 3. ICU Admission and Discharge Criteria 4. Quality Assurance and Improvement 5. ICU Utilization 6. Current Trends in ICU Beds, Use, Occupancy, and Costs in the United States 7. Early Warning Systems for the ICU8. Patient Risk Prediction Model (Severity of Illness Scores) Part 2. Multidisciplinary Care 9. Rapid Response Team 10. Nursing11. Pharmacy 12. Nutrition 13. Physical and Occupational Therapy14. Patient Support15. Advocacy and Social Work16. Chaplaincy Part 3. Advance Practice Providers 17. Role of the APPs in the Onco-ICU18. Credentialing19. CompetenciesPart 4. Clinical Pharmacy 20. Chemotherapy 21. Considerations for Medications Commonly Utilized in the Oncology Population22. Supportive Care ConsiderationsPart 5. Dermatologic Complications 23. GHVD, TEN, and Mycosis Fungoides Part 6. Neurologic Diseases 24. Medication-induced Neurotoxicity 25. Delirium and Psychosis 26. Seizures and Status Epilepticus 27. Stroke 28. Increased Intracranial Pressure (brain mets, ich, hydrocephalus, etc) 29. Posterior Reversible Encephalopathy Syndrome (PRES) 30. Tumor-related Diseases/Neoplastic Meningitis/Leptomeningeal Disease 31. Frequent CNS Infections in the Immunosuppressed Patient 32. Intracranial Hemorrhage Focused on Cancer and Hemato-oncologic Patients33. Spinal Cord Compression 34. TCD in the ICU Part 7. Respiratory Diseases 35. Acute and Chronic Respiratory Failure 36. Oxygen therapy (low-flow and high-flow oxygen therapy) 37. Respiratory Care of the Critically Ill Patient 38. Management of Tracheobronchial Diseases 39. Pulmonary Hypertension 40. ARDS and the differential diagnosis of pulmonary infiltrates in the cancer patient41. Diffuse Alveolar Hemorrhage 42. Differentiation (Retinoic acid ATRA) Syndrome 43. Late Non Infectious Pulmonary Complications in Hematopoietic Stem Cell Transplantation 44. Treatment-related Lung Injury 45. Pneumonia in the Cancer Patient 46. Ventilatory Strategies and Weaning from Mechanical Ventilation 47. Noninvasive Ventilation 48. High Frequency Ventilation 49. Prone Ventilatory Therapy 50. Bi-Level and Airway Pressure Release Ventilation 51. NAVA 52. ECMO in Cancer Patients 53. Tracheostomy: Appropriateness and Indications in Cancer Patients 54. Pleural Disease, Malignant and Benign Pleural Effusions55. Sleep Disorders in the Oncologic ICU Part 8. Cardiovascular Diseases56. Hemodynamic evaluation57. Acute Coronary Syndrome Thrombocytopenia and Antiplatelet Therapy in the Cancer Patient 58. Interventional Cardiology in the Cancer Patient 59. Arrhythmias in the Cancer Patient 60. Management of Pericardial Effusions/Tamponade 61. Chemotherapy-related Cardiovascular Complications 62. Cardiopulmonary Resuscitation in the Cancer Patient Part 9. Gastrointestinal Disease 63. Gastrointestinal Bleeding 64. Malignant Ascites 65. Hepatobiliary Disease66. Acute abdomen in the cancer patient Part 10. Genitourinary Disease 67. Hematuria68. Hemorrhagic cystitis69. Obstructive Uropathy in the Cancer PatientPart 11. Renal Disease 70. Acute Renal Failure71. Renal Replacement Therapy Part 12. Metabolic/Endocrine Complications 72. Adrenal Emergencies 73. Carcinoid Crises 74. Thyroid Emergencies 75. Electrolytic Abnormalities 76. Hypoglycemia and Hyperglycemia in the Cancer Patient Part 13. Hematologic Diseases 77. Malignant Hematological Diseases78. Benign Hematological Diseases 79. Immunology and molecular biology for the intensivist Part 14. Transfusion Medicine 80. Statistics 81. Blood Products 82. Transfusion Reactions 83. Transfusion Related Lung Injury 84. Alternatives to Blood Products85. Massive Bleeding Protocol 86. Transfusion Thresholds Part 15. Vascular Complications 87. Management of Arterial Bleeding 88. Prevention and Management of Venous Thromboembolism in the Cancer Patient 89. SVC Syndrome 90. Catheter-related Deep Vein Thrombosis Part 16. Infectious Diseases 91. Infection Control Procedures 92. Neutropenic Fever 93. Sepsis and Management of Septic Shock 94. Management of Multi-Drug Resistant Organisms 95. Fungal Infections 96. Viral Infections 97. Bacterial and Atypical Infections 98. Catheter and Device Related Infections 99. Nosocomial Infections and Ventilator Associated Pneumonia 100. Protozoal Infections in the Cancer Patients101. Antibiotic Stewardship 102. Tropical diseases in the cancer patient103. Soft tissue infections Part 17. Post-Surgical Care of the Critically Ill Cancer Patient104. Neurosurgery105. Head & Neck Surgery 106. Plastic Surgery & Flap Graft Management 107. Thoracic Surgery 108. GI Surgery 109. Hepatic Surgery 110. Pancreatic Surgery 111. Genitourinary Surgery 112. Orthopedic Surgery 113. Interventional Radiology 114. Radiation Therapy & Gamma Knife Procedures 115. MRI 116. Outpatient Surgery Part 18. Special Patient Populations 117. Management of the Pregnant Critically Ill Cancer Patient 118. Special Considerations of Hemato-Oncologic Critically Ill Patient 119. Pediatric Cancer Critical Care Part 19. Critical Care Procedures 120. ICU Procedures by APP 121. Management of the Airway in the Cancer Patient 122. Use of Ultrasound Guidance 123. Interventional Radiology Procedures Part 20. Ethics 124. Do Not Resuscitate Orders125. Ethics Consultation126. End of Life Care127. Medical FutilityPart 21. Pain Management, Palliative Care, and Outcomes128. Acute Pain 129. Chronic Pain 130. Substance Withdrawal 131. Palliative Care in the critically ill cancer patient 132. Outcomes in Critically Ill Oncologic Patients

Read more less

Book SynopsisSelected as a Doody’s Essential Title for 2025! A vital reference for the entire radiation oncology team, Khan’s The Physics of Radiation Therapy thoroughly covers the physics and practical clinical applications of advanced radiation therapy technologies. Dr. John Gibbons carries on the tradition established by Dr. Khan in previous editions, ensuring that the 6th Edition provides state-of-the-art information for radiation oncologists, medical physicists, dosimetrists, radiation therapists, and residents alike. This updated classic remains the most practical radiation therapy physics text available, offering an ideal balance between theory and clinical application.   Includes new quality conversion factors and procedures for calibration of flattening filter free linacs; new recommendations for Monitor Unit Calculations and Failure Mode and Effects Analysis; a new addition of the Boltzman Transport calculation algorithm, and new optical surface and magnetic resonance image-guided technologies. Contains a new chapter on knowledge-based treatment planning. Covers 3D conformal radiotherapy (3D-CRT), stereotactic radiosurgery (SRS), high dose-rate remote afterloaders (HDR), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), Volumetric Modulated Arc Therapy (VMAT), and proton beam therapy. Discusses the physical concepts underlying treatment planning, treatment delivery, and dosimetry. Enrich Your eBook Reading Experience Read directly on your preferred device(s), such as computer, tablet, or smartphone. Easily convert to audiobook, powering your content with natural language text-to-speech.

Read more less

Book SynopsisTable of ContentsPart I: Symptom Management Section A PAIN 1 How Should Opioids Be Started and Titrated? 2 What Principles Should Guide Opioid Dose Conversions? 3 How Is Patient-Controlled Analgesia Best Used to Control Pain? 4 Which Opioids Are Safest and Most Effective in Patients With Renal or Hapatic Failure? 5 How Should Mathadone Be Started and Titrated in Opioid-Naive and Opioid-Exposed Patients? 6 What Is Neuropathic Pain and How Is It Best Managed? 7 How Are Adjuvant Medications Such as Corticosteroids and NSAIDs Used for Pain Management? 8 What Are the Approaches to Pain in Skeletal Bone Disease? 9 When and How Should Radiotherapy Be Considered for Pain Management? 10 What Principles Should guide the Prescribing of Opioids for Noncancer Pain? 11 How Does the Opioid Epidemic Impact Palliative Medicine Practice? 12 How Does One Approach the Patient With an Opioid Use Disorder? 13 When Should Epidural or Intrathecal Medications and Pumps Be Considered for Pain Management? 14 When Should Nerve Blocks Be Used for Pain Management? Section B DYSPNEA 15 What Interventions Are Effective for Managing Dyspnea in People With Cancer? 16 What Interventions Are Effective for Managing Dyspnea in COPD? 17 What Interventions Are Effective for Managing Dyspnea in Heart Failure? Section C GASTROINTESTINAL 18 What Medications Are Effective in Preventing and Relieving Constipation in the Setting of Opioid Use? 19 How Should Medications Be Initiated and Titrated to Reduce Acute and Delayed Nausea and Vomiting in the Setting of Chemotherapy? 20 How Should Medications Be Initiated and Titrated to Prevent and Treat Nausea and Vomiting in the Clinical Situations Unrelated to Chemotherapy? 21 What Interventions Are Effective for Relieving Acute Bowel Obstruction in Cancer and Other Conditions? Section D ANOREXIA/CACHEXIA/FEEDING DIFFICULTIES 22 What Therapies Are Effective in Improving Anorexia and Weight Loss in Cancer? 23 What Therapeutic Strategies Are Effective in Improving Anoerexia and Weight Loss in Nonmalignant Disease? 24 What Is the Role of Parenteral and Enteral Nutrition in Patients With Cancer and With Noncancer Illness? Section E PSYCHIATRIC SYMPTOMS 25 What Treatments Are Effective for Depression in Palliative Care Settings? 26 How Are Anxiety and Fear Best Treated in Patients With Serious Illness and in Those Facing the End of Life? 27 What Is the Approach to the Patient Seeking a Hastened Death? Section F DELIRIUM 28 What Is Delirium and How Should It Be Managed? 29 What Are Effective Pharmacological and Nonpharmacological Treatments for Delirium? 30 How Do Symptoms Change for Patients in the Last Days/Hours of Life? PART II: Communication 31 Prognosis in Palliative Care: Estimating Prognosis in Serious Illness and Communication Strategies 32 What Are the Key Elements to Having a Conversation About Communicating Serious News and Setting Goals? 33 What Are the Elements of Advance Care Planning and What Is the Evidence That Advance Care Planning Changes Patient Outcomes? 34 What Are the Special Communication Issues Involved in Caring for Pediatric Patients? Part III: Disease-Specific Topics Section A CANCER 35 What Is the Role for Palliative Care in Patients With Advanced Solid-Tumor Malignancies? 36 What Is the Clinical Course of Advanced Solid-Tumor Cancers 37 What Is the Role for Palliative Care in Patients With Advanced Hematologic Malignancies? 38 What Is the Clinical Course of Hematologic Malignancies? 39 What is the Role for Palliative Care in Children With Cancer? 40 What Is the Clinical Course of Pediatric Cancers? Section B DEMENTIA 41 What Is the Clinical Course of Advanced Dementia? 42 What Are Appropriate Palliative Interventions for Patients With Advanced Dementia? Section C ADVANCED LIVER DISEASE 43 What Are the Causes and Complications of Chronic Liver Disease and What Is the Evidence for Palliative Care Delivery to Those Affected by It? 44 What Do We Know About the Symptoms and Palliative Care Needs of People Affected by Liver Disease? Section D BRAIN FUNCTION 45 What Is the Role of Palliative Care and Stroke? 46 What Special Considerations Are Needed for Individuals With Amyotrophic Lateral Sclerosis, Parkinson's Disease, and Multiple Sclerosis? Section E HEART FAILURE 47 What Is the Clinical Course of Advanced Heart Failure and How Do Implanted Cardiac Devices Alter This Course? Section F CHRONIC CRITICAL ILLNESS 48 What Is Chronic Critical Illness and What Outcomes Can Be Expected? Section G HEAD AND NECK CANCER 49 What Special Considerations Are Needed in Patients With Head and Neck Cancer? Section H END-STAGE RENAL DISEASE 50 What Special Considerations Are Needed in Treating Symptoms in Patients With End-Stage Renal Disease, and How Should Patients Who Stop Dialysis Be Managed? 51 What Are Palliative Alternatives to Renal Replacement Therapy for People With Advanced Kidney Failure? Section I PULMONARY 52 What Special Considerations Are Needed for Patients With Advanced Lung Disease? Section J GERIATRICS 53 What Are the Special Needs of Older Adults With Serious Illness? 54 What Are Multimorbidity and Frailty and How Do They Affect the Care of Older Adults? Section K PEDIATRICS 55 What Are Special Considerations for Pediatric Palliative Care? 56 What Are Special Considerations for Dosing Medications in Pediatric Populations? 57 How Are Children With Developmental Diseases and Delays Best Managed in Palliative Care? 58 What Are Special Considerations for Perinatal Palliative Care? 59 What Are Special Considerations for Patients With Cystic Fibrosis? PART IV: Special Topics Section A PALLIATIVE CARE EMERGENCIES 60 What Are the Signs, Symptoms, and Treatments of Spinal Cord Compression? 61 What Framework Can Be Used to Address Uncontrolled Symptoms at the End of Life? Section B FINANCIAL ASPECTS OF PALLIATIVE CARE 62 What Are the Arguments That Show That Palliative Care Is Beneficial to Hospitals? 63 What Are the Arguments That Show That Outpatient Palliative Care Is Beneficial to Medical Systems? Section C CAREGIVERS 64 How Does Serious illness Affect Family Caregivers? 65 What Can Be Done to Improve Outcomes for Caregivers of People With Serious Illness? 66 What Is Prolonged Grief Disorder and How Can Its Likelihood Be Reduced? Section D SETTINGS FOR PALLIATIVE CARE DELIVERY 67 What Are the Models for Delivering Palliative Care in Hospitals? 68 What Models Exist for Delivering Palliative Care and Hospice in Nursing Homes? 69 What Are the Models for Delivering Palliative Care in the Ambulatory Practice Setting? 70 What Are the Models for Delivering Palliative Care in the Home? 71 What Are the Models for Delivering Palliative Care in Rural Areas? 72 How Is Palliative Care Best Integrated Into Surgical Services? 73 What Models Exist to Deliver Palliative Care via Telemedicine? 74 What Are National Strategies and Frameworks for Palliative Care? 75 What Are Sources of Spiritual and Existential Suffering for Patients With Advanced Illness? 76 What Are the Racial and Ethnic Health Disparities That Exist in Palliative Care? 77 What Are the Palliative Care Needs of LGBTQ+ People? 78 What Is the Evidence for Integrative and Alternative Therapies in Palliative Care? 79 What Is the Evidence Supportng the Use of Mobile Health Technologies in Palliative Care? 80 How Can Clinician Well-Being Be Improved and Sustained in Palliative Care?

Read more less

Book SynopsisLike the first edition, this is a seminal textbook for the advanced practice nursing care of the seriously ill and dying. This comprehensive work addresses all aspects of palliative care including physical, psychological, social, and spiritual needs. It brings to the forefront current issues of health equity, managing through crisis, and meeting the needs of diverse populations. Each chapter contains case examples and a strong evidence base to support the highest quality of care. The text is written by leaders in the field and includes authors who have pioneered the role of the advanced practice nurse in palliative care. This volume offers advanced practice content and practical resources for clinical practice across all settings of care and encompassing all ages, from pediatrics to geriatrics.This newly revised edition has been reorganized to meet the needs of the APRN according to role delineation and practice issues. It offers foundation information on leadership, practice, and the Table of ContentsPreface Acknowledgments List of Contributors Section I The Palliative APRN 1 Palliative APRN Practice and Leadership: Past, Present, and Future Constance Dahlin and Patrick J. Coyne 2 Fundamental Skills and Education for the Generalist and Specialist Palliative APRN Dorothy Wholihan, Charles Tilley, and Adrienne Rudden 3 Credentialing, Certification, and Scope of Practice Issues for the Palliative APRN Kerstin Lea Lappen, Matthew McGraw, and Kate Meyer Section II Palliative APRN Roles 4 The Palliative APRN in Administration Karen Mulvihill 5 The Palliative APRN in Nursing Education Carrie L. Cormack and Kathleen O. Lindell 6 The Palliative APRN in Policy and Payment Models Marian Grant 7 The Palliative APRN in Research and Evidence-Based Practice Janice Linton and Joan G. Carpenter Section III Clinical Settings of Palliative APRNs 8 The Palliative APRN in the Medical, Surgical, and Geriatrics Patient Care Unit Phyllis B. Whitehead and Carolyn White 9 The Palliative APRN in the Intensive Care Setting Clareen Wiencek 10 The Palliative APRN in the Emergency Department Sarah Loschiavo and Angela Starkweather 11 The Palliative APRN in the Palliative Care Clinic Brooke Smith and Lisa A. Stephens 12 The Palliative APRN in Primary Care Rosemary Gorman, Dorothy Wholihan, and Sarah Bender 13 The Palliative APRN in Specialty Cardiology Beth Fahlberg, Ann Laramee, and Erin Donaho 14 The Palliative APRN in the Community Setting Nicole DePace 15 The Palliative and Hospice APRN in Hospice and Home Health Programs Rikki N. Hooper, Chari Price, and Jamie Lee Rouse 16 The Palliative APRN in Rehabilitation Lorie Resendes Trainor 17 The Palliative APRN in Telehealth Katherine Kyle and Constance Dahlin 18 The Palliative APRN in the Rural Community Traci Sickich 19 The Palliative APRN in Residential Facilities Melissa McClean and Victoria Nalls Section IV Populations at Risk 20 Health Disparities in Palliative Care and Social Determinants of Health Alma Y. Dixon and Cecilia R. Motschenbacher 21 Economically Disadvantaged Urban Dwellers Natasha Curry 22 Inclusive Palliative Care within the LGBTQ+ Community Jessica Nymeyer 23 Care of Veterans with Palliative Care Needs Alice C. Foy, Robert David Rice, and Joseph Albert Melocoton 24 Recurrent Disease and Long-Term Survivorship Denice Economou and Brittany Bradford Section V Pediatric Palliative Care 25 The Pediatric Palliative APRN Cheryl Ann Thaxton and Nicole Sartor 26 The Pediatric Palliative APRN in the Acute Care Setting Faith Kinnear and Gina Santucci 27 The Pediatric Palliative APRN in Perinatal and Neonatal Palliative Care Maggie C. Root and Mallory Fossa 28 The Pediatric Palliative APRN in the Clinic Alice Bass and Vanessa Battista 29 The Pediatric Palliative APRN in Oncology Amy Corey Haskamp and Joanne M. Greene 30 The Pediatric Palliative APRN in the Community Joan "Jody" Chrastek and Jaime Hensel 31 Communication in Pediatric Palliative Care Mallory Fossa, Julia McBee, and Rachel Rusch Section VI Communication in Palliative Care 32 Advance Care Planning: Advance Directives, Medical Order Sets, and Surrogate Decision-Making Hannah N. Farfour 33 Family Meetings Jennifer Gentry, Kerrith McDowell, and Paula McKinzie 34 Communication at the End of Life Marlene E. McHugh, Penelope R. Buschman, and Susan M. Delisle Section VII Psychosocial, Cultural, and Spiritual Aspects of Care 35 Culturally Respectful Palliative Care Helen Foley and Polly Mazanec 36 Ensuring Quality Spiritual Care Betty Ferrell 37 Life Review Jamil Davis, Mimi Jenko, and James C. Pace 38 Grief and Bereavement Katharine Adelstein and Elizabeth Archer-Nanda Section VIII Symptoms 39 Anorexia and Cachexia Robert Smeltz and Renata Shabin 40 Bowel Symptoms Kimberly Chow and Lauren Koranteng 41 Fatigue Shila Pandey 42 Nausea and Vomiting Katherine E. DeMarco 43 Pain Judith A. Paice 44 Respiratory Symptoms Ember S. Moore and Kathleen Broglio 45 Cognitive Impairment Abraham A. Brody and Donna E. McCabe 46 Serious Mental Illness Kristyn Pellecchia and Ryan Murphy 47 Patients with Substance Use Disorders and Dual Diagnoses Jeannine M. Brant and Tonya Edwards 48 Anxiety Kira Stalhandske 49 Delirium Bonnie D. Evans and Erica J. Hickey 50 Depression and Suicide John Chovan 51 Palliative Emergencies Ann Quinn Syrett, Marcia J. Buckley, and Beth Carlson 52 Challenging Symptoms: Pruritus, Hiccups, Dry Mouth, Fevers, and Sleep Disorders Barton T. Bobb and Devon S. Wojcikewych Section IX Ethical Considerations 53 Navigating Ethical Dilemmas Nessa Coyle and Timothy W. Kirk 54 Discontinuation of Cardiac Therapies Patricia Maani Fogelman and Janine A. Gerringer 55 Discontinuation of Respiratory Therapies Brenna Winn 56 Discontinuation of Other Life-Sustaining Therapies Kathy Plakovic and Jennifer Donoghue 57 Palliative Sedation David Collett and Kelly Baxter Appendix I Palliative APRN Billing and Coding Constance Dahlin Appendix II Perinatal and Pediatric Pain and Symptom Tables Constance Dahlin, Amy Corey Haskamp, Joanne Greene, Maggie Root, Mallory Fossa, Faith Kinnear, Alice Bass, Nicole Sarter, Gina Santucci, Cheryl Thaxton, Jaime Hensel, Jody Chrastek, and Vanessa Battista Index

Read more less

Book SynopsisOncology and Cellular Biology.- 1. Recent Developments in the Treatment of Bladder Cancer.- 2. Interferon-? Response and Signal Transduction Pathway in Transitional Carcinoma Cell Lines.- 3. Molecular Cloning and Expression of Uroplakins in Transitional Cell Carcinoma.- 4. Application of a Novel Protein Chip Mass Spectrometry Technology for the Identification of Bladder Cancer-Associated Biomarkers.- 5. The Photodynamic Diagnosis (PDD) for Early Detection of Carcinoma and Dysplasia of the Bladder.- 6. Prediction of Lymph Node Metastasis Based on P53 and nm23-Hl Expression in Muscle Invasive Grade III Transitional Cell Carcinoma of Bladder.- 7. Detection of HER-2/neuCEP 17 Mutations at Invasive Bladder Cancer.- 8. Ki67, P53, nm23, and DNA Cytometry in Bladder Cancer: Potential Markers for Detection of Recurrence.- 9. Comparison of Cytology and Nuclear Matrix Protein 22 (NMP 22) for the Detection and Follow-Up of Bladder Cancer.- 10. The Effect of Contrast Material on Transitional Cell CTable of ContentsOncology and Cellular Biology.- 1. Recent Developments in the Treatment of Bladder Cancer.- 2. Interferon-? Response and Signal Transduction Pathway in Transitional Carcinoma Cell Lines.- 3. Molecular Cloning and Expression of Uroplakins in Transitional Cell Carcinoma.- 4. Application of a Novel Protein Chip Mass Spectrometry Technology for the Identification of Bladder Cancer-Associated Biomarkers.- 5. The Photodynamic Diagnosis (PDD) for Early Detection of Carcinoma and Dysplasia of the Bladder.- 6. Prediction of Lymph Node Metastasis Based on P53 and nm23-Hl Expression in Muscle Invasive Grade III Transitional Cell Carcinoma of Bladder.- 7. Detection of HER-2/neuCEP 17 Mutations at Invasive Bladder Cancer.- 8. Ki67, P53, nm23, and DNA Cytometry in Bladder Cancer: Potential Markers for Detection of Recurrence.- 9. Comparison of Cytology and Nuclear Matrix Protein 22 (NMP 22) for the Detection and Follow-Up of Bladder Cancer.- 10. The Effect of Contrast Material on Transitional Cell Carcinoma Viability.- 11. Fluorodeoxyglucose Positron Emission Tomography Studies in the Diagnosis and Staging of Transitional Cell Carcinoma.- 12. Radiochemotherapy in Locally Invasive Non-Metastatic Carcinoma of the Bladder.- 13. Gene and Antisense Therapy of Bladder Cancer.- 14. Tumor Suppressor Genes of Bladder Cancer and Potential for Gene Therapy.- Muscle, Matrix, and Obstruction.- 15. Molecular Response of the Bladder to Obstruction.- 16. The Role of Lipids and Lipid Metabolites in Urinary Bladder Dysfunction Induced by Partial Outlet Obstruction.- 17. Intercellular Communication and Bladder Function.- 18. Ischemia as an Etiological Factor in Bladder Instability: Implications for Therapy.- 19. Effect of Chronic Ischemia on Bladder Structure and Function.- 20. Ultrastructural Diagnosis of Neuropathic Detrusor Overactivity: Validation of a Common Myogenic Mechanism.- 21. Serial Changes of Smooth Muscle Cell Phenotypes in Rat Urinary Bladder Following Partial Outflow Obstruction.- 22. Study of Detrusor Dysfunction Due to Outlet Obstruction: Link Between Analysis of Uroflows of Men with Benign Prostatic Hyperplasia and Animal Studies.- 23. Ultrasonic Measurement of Bladder Weight as a Novel Urodynamic Modality.- Neurophysiology, Neurogenic Bladder, and Incontinence.- 24. Experimental Neurogenic Cystitis.- 25. Murine In Vitro Whole Bladder Physiology.- 26. Ca2+ Sparks and KCa Channels: Novel Mechanisms to Relax Urinary Bladder Smooth Muscle.- 27. The Effect of Intravesical Capsaicin and Resiniferatoxin in Neurogenic Bladder Dysfunction.- 28. On the Physioanatomy of Micturition and Urinary Continence-New Concepts.- 29. Stress Urinary Incontinence: New Concept of Pathogenesis and Treatment by Pudendal Canal Decompression.- 30. Transcutaneous Electrovesicogram in Normal Volunteers and Patients with Interstitial Cystitis, Neurogenic Bladder, Benign Prostatic Hyperplasia, and after Cystectomy.- 31. Extracorporeal Electromagnetic Stimulation for Urinary Incontinence and Bladder Disease.- 32. Pubovaginal Sling Surgery without Using Abdominal Leak Point Pressure: An Outcomes Analysis.- 33. The Use of Synthetic Materials in Pubovaginal Sling.- 34. Surgical Implantation of the Synthetic Sling (The 6-Point Fixation Technique and Weight-Adjusted Spacing Nomogram): Technique and Results.- 35. Reconstructive Surgery in Neuropathic Bladder.- 36. The Role of the Simple Cystectomy in Urologic Surgery.- Immunology, Inflammation, and Infection.- 37. Neurogenic Inflammation of the Bladder.- 38. Urine-Induced Apoptosis in Cultured Bladder Urothelial Cells.- 39. Bacillus of Calmette and Guerin Modulates Nuclear Factor Kappa ? in Two Urothelial Carcinoma Cell Lines.- 40. Induction of Urothelial Cell Proliferation by Fibroblast Growth Factor-7 in RAG 1-Deficient Mice.- 41. Development of a Recombinant FimCH Vaccine for Urinary Tract Infections.- 42. Intravesicular Pain Mapping.- 43. A Hypothesis for the Etiology of Interstitial Cystitis.- 44. Pentosanpolysulfate (Elmiron) is a Potent Inhibitor of Mast Cell Histamine Secretion.- 45. The Efficacy of Intravesicular Sterile Sodium Chondroitin Sulfate 0.2% in Potassium Tested Positive Patients with Interstitial Cystitis.- 46. Cystectomy Causes Immunosuppression in Bladder Cancer.- New Frontiers and Therapies.- 47. Nocturia.- 48. The Fate of Urinary Bladder Smooth Muscle after Outlet Obstruction—A Role for the Sarcoplasmic Reticulum.- 49. Alteration of Collagen Three-Dimensional Architecture in Noncompliant Human Urinary Bladder.- 50. Modulation of Angiogenesis: Experimental Strategies and Potential Therapeutic Applications.- 51. Methods of Testing Urethral Resistance in the Female Rat.- 52. Virtual Reality Surgical Simulation for Lower Urinary Tract Endourologic Surgery.- 53. Autologous Muscle Transfer for Reconstruction of the Lower Urinary Tract.- 54. Effectiveness of Denuding the Intestinal Mucosa by Submucosal Injection in the Porcine Model.- 55. Urinary Diversion in the Management of Chronic Perineal Skin Ulceration in Spinal Cord Injured Patients Following Sphincterotomy.- 56. The Artificial Urinary Bladder.- 57. Comparison of the Breaking Strength of Polyglactin Mesh in Urine, Serum, and Cell Culture Media.- 58. Growth of Cultured Human Urothelial Cells Into Stratified Urothelial Sheet Suitable for Autografts.- 59. Future Perspectives in Bladder Reconstruction.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less